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ABSTRACT 
Multispectral Optical Imaging for the Detection and Delineation of Oral Neoplasia 
by 
Darren Michael Roblyer 
Despite the accessibility of the oral cavity to inspection, patients with oral cancer 
most often present at a late stage, leading to high morbidity and mortality. Multispectral 
widefield optical imaging has emerged as a promising technology to aid clinicians in 
screening and resection of oral neoplasia, but current approaches rely on subjective 
interpretation. This work focuses on the design, construction, and clinical testing of a 
novel multispectral widefield optical imaging device for objective screening and 
delineation of oral neoplasia. 
The Multispectral Digital Microscope (MDM) acquires in vivo images of oral tissue 
in autofluorescence, narrow band reflectance, and orthogonal polarized reflectance modes 
that the diagnostic value of each modality may be qualitatively and quantitatively evaluated 
alone and in combination. 
Using in vivo imaging data collected from 56 patients and 11 normal volunteers, 
combined with computer aided diagnostics, a sensitivity of 100% and a Specificity of 
91.4% was achieved for discriminating oral dysplasia and cancer from normal tissue in an 
independent validation set. A single feature calculated from the autofluorescence images 
at 405 nm excitation was used to achieve this performance. Disease probability maps 
were constructed using this feature to help identify areas with a high probability of 
abnormality. Autofiuorescence imaging at 405 nm excitation also provided the greatest 
image contrast which was significantly higher than that using standard white-light 
illumination. Features extracted from other imaging types did not appear to aid in 
diagnosis. 
Ex vivo image data from the MDM was combined with image data from a high-
resolution microendoscope (HRME) in order to determine if a synergistic relationship 
existed between these devices. The ability to objectively diagnose oral lesions 
substantially increased when using both devices in combination compared to using either 
alone. This combination of devices provides a practical means of screening the entire 
mucosal surface for suspicious regions, using the MDM, and then using the HRME for 
confirmation of diagnosis. 
This work has demonstrated that widefield autofiuorescence imaging at 405 nm 
excitation can be highly effective for the objective discrimination of oral lesions. 
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CHAPTER 1: INTRODUCTION 
1.1 Overview 
One in three Americans will be diagnosed with cancer within their lifetimes [1]. 
Although there have been significant improvements in treatment during the last 50 years, 
there has only recently been a slight decline in cancer mortality in the United States [2]. 
Early detection, however, can greatly increase a patient's chance of survival and often 
responds to simpler, less expensive, and less invasive interventions. When implemented 
correctly, early detection programs have the added benefit of reducing the burden on our 
national healthcare system. Early detection methods which are robust, relatively 
inexpensive, and require minimal expertise and training have the added potential to help 
combat rising mortality due to cancer in developing countries. 
Oral cancer contributes significantly to the global cancer burden. In the US alone, 
there are an estimated 30,000 cases of oral cancer diagnosed and 7,320 deaths annually 
[3]. The incidence of disease increases dramatically in some developing nations and 
ranks as the sixth most common cancer globally [4]. The accessibility of the oral cavity 
makes is an ideal location for inspection and early detection, which can greatly improve 
survival. The five-year survival rate for oral cancer patients with advanced stages of 
disease is 17% but improves to 80% if diagnosed at local stages of development [5]. 
The most common detection methods for oral cancer in the US include visual 
inspection during routine dental visits and self referral by patients followed by invasive 
biopsy for confirmation. There are currently no widely implemented standards for oral 
cancer screening by dental practitioners and often decisions for further investigation of 
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suspicious areas are made based on experience. The situation is further complicated by 
the plethora of common benign conditions which can occur in the oral cavity. There are 
several screening aids commercially available but to date, all remain subjective in nature 
and confirmatory biopsies are still required. 
An accurate and objective screening technique would provide great benefit to the 
global population and high risk populations in particular. Additionally, methods for 
improving the delineation of the extent or margin of malignant lesions in the oral cavity 
would aid in treatment methods such as surgical resection. 
The vast majority of malignancies in the oral cavity begin in the epithelium at the 
junction between the epithelial and stromal tissue layers called the basement membrane. 
Growth of abnormal cells then progresses upward to the tissue surface before breaking 
through the basement membrane. The tissue depth of morphologic and biochemical 
changes in tissue (typically several hundred micrometers) which accompany malignant 
progression, coupled with the accessibility of the oral cavity, make oral cancer an ideal 
candidate for inspection with optical technologies. Visible light has a penetration depth 
in tissue which corresponds to the location of these changes. Recent advances in the 
understanding of the biological basis of the optical changes which occur in tissue during 
malignant progression, including autofluorescence signatures, help provide support to the 
idea that optical imaging, with appropriate illumination and collection conditions and 
wavelengths, can greatly improve the detection and delineation of oral premalignancies 
and malignancies [6]. 
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1.2 Specific Aims 
The overall goal of this dissertation was to elucidate the extent to which widefield 
multispectral optical imaging could improve diagnosis and delineation of oral neoplasia. 
The specific aims of the work were to: 
Specific Aim 1: Design, construct, and characterize the performance of a widefield 
multimodal optical microscope capable of narrowband reflectance, polarized reflectance, 
and autofluorescence imaging. Use this system to study both endogenous elastic light 
scattering and autofluorescence features of precancerous and cancerous lesion in the oral 
cavity. Additionally, determine resolution, field of view, exposure times and other 
performance indicators of the MDM. 
Specific Aim 2: Test the performance of the MDM for detecting pre-cancerous and 
cancerous lesions in the oral cavity using criteria such as sensitivity and specificity. 
Using data from an in vivo pilot clinical study of 72 consenting patients, extract 
quantitative image features and use computer aided diagnosis algorithms to determine 
performance. Intrinsic in this analysis are the determination of the imaging modalities 
and specific illumination and collection wavelengths which provide the greatest 
diagnostic utility. Additionally, determined to what extend the MDM can provide a 
specific graded diagnosis (i.e. grades of dysplasia). Finally, quantify image contrast to 
determine the modalities/wavelengths which provide the highest image contrast. 
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Specific Aim 3: Combine imaging results from the MDM with a high resolution 
microendoscope developed in our lab to reveal if this combination can provide increased 
diagnostic performance. Analyze data from resected tissue from 14 patients and utilize 
hybrid consensus techniques to determine diagnostic performance from the synthesis of 
two separate classification algorithms for the devices. 
1.3 Chapter Summaries 
This dissertation describes the development and usage of a novel, objective, oral 
cancer screening device based on multispectral optical imaging. The device was 
designed as a research grade scientific tool to explore the optical modalities and 
conditions which could provide improved information on the presence and location of 
oral lesions in vivo. Although previous studies have been conducted to investigate the 
ability of some specific imaging modalities to identify lesions, this is the first work to 
combine multiple modalities including autofluorescence, narrowband, and polarized 
imaging at multiple illumination and collection wavelengths and quantitatively compare 
results. Additionally, this work is the first to attempt quantification of the most common 
observations and implementation of computer aided diagnostics for the diagnosis of 
malignant lesions in the oral cavity with the aim of developing an objective screening and 
delineation tool. This work is extended by combining widefield multispectral imaging 
results with a high resolution optical imaging device, with the aim of further improving 
detection. 
Chapter 2 provides background on the motivation for this work, and briefly 
reviews the biology of oral cancer. The biochemical and morphological changes which 
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occur during malignant progression are described as well as how these changes can be 
exploited by optical technologies for improved detection. Additionally, this chapter 
provides an overview of the current screening and detection methods available for oral 
cancer and limitations of these techniques. Finally, Chapter 2 provides a description of 
how computer aided diagnostics can be implemented with optical imaging. 
Chapter 3 details the design criteria and construction of the device which will now 
be referred to as the Multispectral Digital Microscope (MDM), as well as initial 
qualitative observations from study subjects. This chapter describes the specific 
modalities of the MDM, including autofluorescence, narrow reflectance, and orthogonal 
polarized reflectance modes, which were used to acquired in vivo image data from oral 
tissue to allow evaluation of lesions which may not exhibit high contrast under standard 
white light illumination. The chapter continues with qualitative observations of the 
visual appearance of oral lesions using different imaging modalities. For example, 
changes in vascular patterns, contrast, and color are described on lesions and tissue from 
normal volunteers. 
Chapter 4 provides an in depth analysis of autofluorescence imaging mode, which 
appeared to be highly useful based on results presented in Chapter 3. This chapter 
describes a quantitative method to extract image features and their use for objective, 
computer aided diagnosis of tissue regions. Data collected from an in vivo clinical study 
of 56 patients with oral lesions and 11 normal volunteers was utilized. From these 
images, 276 measurements from 159 unique regions of interest (ROI) sites corresponding 
to normal and confirmed neoplastic areas were identified. Data from ROls in the first 46 
subjects was used»to develop a simple classification algorithm based on the ratio of red-
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to-green fluorescence; performance of this algorithm was then validated using data from 
the ROIs in the last 21 subjects. This algorithm was applied to patient images to create 
visual disease-probability maps across the field of view. Histologic sections of resected 
tissue were used to validate the disease-probability maps. 
Chapter 5 expands on the analysis conducted in Chapter 4 and includes the other 
imaging modalities and image types provided by the MDM in the computer aided 
diagnosis analysis. This chapter also quantifies the increase in optical image contrast 
seen using the different imaging modalities. Five new patients were added from Chapter 
4 so that analysis was conducted on 61 patients with oral dysplasia and/or cancer and 11 
normal volunteers. Image contrast of oral lesions compared to healthy tissue was 
computed and compared for all image types. Computer aided diagnosis was performed 
on the image data using a linear classifier and a decision tree classifier to explore the 
image types and extracted features which provide the best objective diagnosis. 
Based on results from the previous chapters it was clear that the MDM could 
provide accurate identification of oral lesions in a tertiary care patient population. There 
are several questions and foreseeable limitations that this technology could encounter in a 
more diverse screening population. With this in mind, Chapter 6 explores combining the 
MDM analysis with results obtained from a high resolution microendoscope developed 
by our group. An underlying practical implication of combining these devices is that the 
MDM can provide rapid screening of the entire oral mucosal surface, or in this case, an 
entire resected specimen, and suspicious areas can be identified. The high resolution 
system can then interrogate these areas to help confirm a diagnosis. 
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This study involved a combined analysis including image data collected by the 
MDM and the high resolution microendocope system from ex-vivo tissue resected from 
14 patients with oral precancers and cancer. Several methods of combining extracted 
image feature data from both devices were explored based on hybrid consensus 
techniques. 
Chapter 7 provides a discussion of the implications of results from this 
dissertation work as well as potential future work. Chapter 8 provides a conclusion for 
the Work. 
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CHAPTER 2: BACKGROUND 
2.1 Motivation 
Oral cancer poses a significant and largely preventable world health problem. Oral 
and pharyngeal cancer ranks as the sixth most common cancer globally [4]. In the US, 
there were an estimated 30,000 cases of oral cancer diagnosed and 7,320 deaths in 2005 
[3]. The incidence is two times greater in men than woman and risk factors such as 
tobacco, including cigarettes, cigars, pipes, and smokeless tobacco, as well as alcohol, 
ultraviolet light, and poor nutrition greatly increase chances of developing oral cancers. 
Specific regional practices such as chewing of the betel nut in some parts of the world, 
and the areca quid chewing habit popular in Taiwan, can also increase incidence [7,8]. 
Oral cancer has a high mortality rate because it is often diagnosed during late stage 
disease, when symptoms normally occur. If not caught by routine dental or doctor's visit, 
oral cancers are often only diagnosed after a patient complains of pain or irritation 
resulting due to the cancer. In the US, the five-year survival rate for localized disease is 
81% but for those with distant metastases is only 17% [5] showing that early detection 
has the ability to save a large number of lives. 
2.2 Anatomy, Etiology, Histology and Progression of Disease 
In the US, oral cancer occurs most frequently in the tongue (30% of cases) 
followed by lip (17%), floor of mouth (14%), gingiva, hard palate, soft palate, and buccal 
mucosa [4]. Over 90% of oral cancers are squamous cell carcinomas (SCCs) whose 
tissue of origin is the epithelial lining of the oral cavity or oropharynx. Differences in the 
epithelial lining of the regions of the oral cavity include a nonkeratinized mucosal lining 
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and loose lamina propria in the buccal, soft palate, floor of mouth and inner lip, and a 
superficial keratin layer on the dorsal tongue, hard palate, and gingiva. [9] The 
transformation from normal tissue to cancer may occur over a widely varying amount of 
time from several months to many years and includes abnormal cellular changes. 
Cellular transformations often begin at the basal layer and progress upward through the 
epithelium. This upward progression of cellular changes is called dysplasia. There is 
uncontrolled cell division and the typical progression from tall cells in the basal layer to 
flattened squamous cells on the surface may be replaced by disordered and abnormally 
shaped basal cells which are mitotic. There are several common cellular morphological 
and anatomical changes at this stage such as a variation in cell shape and size 
(pleomorphism), an increase of DNA content due to increased mitosis causing an 
increased nuclear to cytoplasmic ratio, and changes in chromatin texture which may 
cause nuclei to be deeply stained (hyperchromatism) [10-12]. Changes due to increased 
metabolic activity associated with malignant transformations occur and an increase of 
metabolic co-factors such as reduced forms of nicotinamide adenine dinucleotide 
(NADH), flavin adenine dinucleotide (FAD) [13]. Levels of aromatic amino acids such 
as tryptophan, tyrosine, and phenylalanine as well as porphyrins may also increase[14]. 
Stromal changes such as increase in collagen content or the breakdown of collagen 
crosslinks may occur during the transformation [10]. 
Since the progression of cancer is intimately linked to increased environmental stimuli 
and a cell's ability to replicate uncontrollably, certain biomarkers have been identified 
which are over expressed in cancers. In many cancers, including cancer of the oral 
cavity, it has been shown that epithelial growth factor receptor (EGFR), a tyrosine kinase 
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protein is expressed in proportion to the stage of malignant transformation [15,16]. 
Additionally, matrix-metalloproteases such as MMP-2 and MMP-9 have been shown 
through studies of immunohistochemical staining of oral cancer tissue sections to be 
overexpressed in a majority of oral cancers [17,18] 
2.3 Optically Detectable Changes in Tissue 
Optically detectable changes which occur in oral mucosal tissue during malignant 
transformation include changes in light scattering properties in bulk tissue due to 
underlying cellular changes, vasculature pattern changes due to angiogenesis, changes in 
native tissue fluorescence, and changes in the content of absorbers such as hemoglobin 
[19][6]. 
Modeling efforts have shown that the scattering cross section of dysplastic cells in 
the cervix is increased in comparison to normal cells due to nuclear morphology [12]. 
These changes may be analogous in the oral cavity and may be detectable using 
reflectance imaging modalities. 
Changes in the autofluorescence of dysplastic and malignant tissue have been 
observed optically and there has been significant investigation into the cause of these 
changes. Changes in metabolic activity in premalignant tissue may be responsible for 
changes in the concentration of fluorescent metabolic byproducts. Among those 
substances, structures, or molecules suspected of being responsible for increased 
fluorescence are NADH, FAD, porphyrins, tryptophan, tyrosine, and phenylalanine. 
Tissue remodeling may also cause reduced fluorescence intensity due to the breakdown 
of collagen and elastin crosslinks. There has been significant research done into 
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discovering what excitation and emission wavelengths can be used to visualize these 
fluorophores. These wavelengths as well as the peaks of some of these fluorophores 
excitation and emission wavelengths are shown in table 1. 
A study examining autofluorescence confocal imaging of freshly resected oral 
tissue by Pavlova et al. demonstrated that there is a strong autofluorescence signal from 
the stroma in normal tissue likely from structural components such as collagen and 
elastin crosslinks. This autofluorescence decreases significantly in both benign and 
dysplastic tissue. In the epithelium, dysplastic tissue showed an increase in 
autofluorescence whereas benign tissue showed a decrease [6]. 
Studies from dysplastic tissue from the cervix, with is histologically similar to 
oral tissue, showed a similar decrease in stromal autofluorescence. Pavlova et. al. 
showed that precancerous cervical tissue shows increased fluorescence in the epithelium 
due to NADH and mitochondrial FAD and decreased fluorescence in the stroma due to 
decreased density of matrix fibers [10]. Drezek et. al. showed increased epithelial 
fluorescence in cervical tissue sections due to NADH and a decrease in stromal 
fluorescence due to fewer collagen cross-links [20]. 
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Table 1. Excitation and emission wavelengths for endogenous 
fluorophores and the tissue discussed in reference. 
Fluorophore Excitation >. Emission >. Tissue Reference 
NADH 290-370 
FAD 430-460 
Collagen & Elastin 300-3 70 
Tryptophan 280-290 
Protoporphyrin IX 410 
Tyrosine 270 
2.4 Current Detection Methods 
Visual preclinical indicators of cancer in the oral cavity may include leukoplakia 
(white pathes) or erythroplakia (red patches) [4,21]. Because of the accessibility of the 
oral cavity to identify these conditions, visual inspection at a routine dental visit is 
currently the most common detection method. This method relies heavily on the 
experience and skill of the physician. Mistakes are easily made, however, because many 
benign conditions mimic the physical presentation of precancerous lesions. The 
sensitivity and specificity of visual oral examination has been systematically reviewed 
by Downer et al [22]. Downer identified eight prospective studies between 1980 and 
2002 that involved conventional oral exam with gold standard verification provided by an 
expert observer. In four of the studies the screeners were general dentists and in four of 
the studies the screeners were trained health workers. Sensitivity ranged from 59% to 
97%, specificity ranged from 75% to 99%, and meta-analysis resulted in a weighted 
pooled sensitivity of 85% and a specificity of 97%. Other reports of the performance of 
440,460 Oral, CervicaLBreast 
515-520 Oral, CervicaLBreast 
400,440 CervicaLBreast 
340 Cervical,Breast 
635 Oral 
300 Cervical 
Pavlova et al. 2003, Drezek et al 2003, Palmer et 
al. 3X13, Rkhards-Kortum et al, 1996 
Pavlova et a l 2003, Drezek et al. 2003, Palmer et 
al. 2003, Richards-Kortum et al. 1996 
Drezek et al 2003, Palmer et al. 2003, 
Richards-lvortutn et al. 1996 
Ingrains el al. 1997, Palmer etal. 2003 
Ingrains el al 1997, Belz et al. 2002 
Drezek et al., 200.1, Richards-Komun el al. 1996 
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visual oral screening include Sankaranarayanan et al (sensitivity 77%, specificity 76%) 
[23], Ramadas et al (sensitivity 82%, specificity 85%) [24], and Nagao et al (sensitivity 
92%, specificity 64%) [25]. 
Invasive biopsy with histological examination is standard clinical practice but this 
method has drawbacks such as pain induced by physical biopsy and reluctance of 
physicians to perform biopsies for a condition that very well may be benign. To increase 
sensitivity of visual inspection, studies using vital dyes such as toluidine blue and Lugol's 
iodine solution have been performed with the drawback of having a high specificity 
[26,27]. 
Fluorescence and reflectance spectroscopy has been explored as a noninvasive 
detection method in several epithelial cancers including oral cancer [8,28-33]. The 
procedure generally involves collecting a spectrum from tissue using a point prove device 
either in vivo or ex vivo from a pre-malignant or malignant region and comparing it to a 
normal tissue spectrum from the same patient or study subject. This technique has shown 
promise in distinguishing normal tissue from dysplastic tissue but has the weakness of 
being able to sample only a small portion of. In vivo confocal and optical coherence 
tomography of the oral cavity to visualize malignant transformations at the cellular level 
are being investigated and show promise but may also be limited by a small field of view 
(typically 200-400um) [34,35]. 
Widefield optical imaging has been studied in the cervix, gastrointestinal tract, 
lung, and oral mucosa and this method has the advantage of a large field of view (several 
centimeters) with the potential to detect changes in scattering properties of tissue as well 
to detect native tissue autofluorescence [14,36-50]. In the oral cavity, sensitivity and 
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specificity of diagnosis of severe dysplasia and cancer have been reported as high as 98% 
and 100% respectively for small sample sizes using visual autofluorescence techniques 
[21]. The device used in this study is currently FDA approved and excites tissue in 
autofluorescence mode between 400 and 450 nm. Other studies from both in-vivo and 
ex-vivo tissue have reported optimal excitation wavelengths for imaging oral cavity 
autofluorescence as 350, 380, 400, 420-440 nm excitation [51-54]. Most studies of 
autofluorescence imaging report qualitative observations of a decrease in blue/green 
fluorescence signal on oral lesions and/or and increase in red fluorescence [55]. 
Currently, these qualitative changes have not been described quantitatively. 
2.5 Computer Aided Diagnostics 
2.5.1 Overview 
Automated or computer aided diagnosis based on imaging data has been 
demonstrated in multiple organ sites using instrumentation systems such as optical 
coherence tomography, mammography, and colposcopic images [56,57][58]. Numeric 
features are extracted from images or regions of images either in an automated manner or 
with a user selected region of interest (ROI). These features can describe any number of 
properties of the image data including statistical measures, textural measures, frequency 
domain measures, and colormetric measures. Often these features attempt to quantify 
some qualitative observation made from the imaging data. For example, texture analysis 
attempt to quantify qualitative descriptors such as smooth or rough. A classification 
algorithm can be trained using these features extracted from collected measurements, and 
used to discriminate new measurements into two or more classes. Classes may be 
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diagnostic categories such as normal and abnormal, where the abnormal class could 
contain data collected from the disease tissue the user is attempting to detect. The gold 
standard for this case is often histopathology. 
There are many different kinds of classification algorithms. In this work I will 
limit the background discussion to a linear discriminant classifier which is based on 
estimating the statistical distribution of the measurements, and a decision tree classifier, 
which is a non-parametric classifier. The feature values extracted from the each image or 
image region form a measurement vector. Measurements may be separated into a 
training set and a test set. The classification algorithm is trained on the training set and 
the performance of the algorithm is determined from the test set. In the case of a small 
sample size, resampling methods such as cross-validation may be used. 
2.5.2 Classification Algorithms 
The linear discriminant function utilizes the Bayes decision rule for minimum-
error-rate classification [59-61]. Multivariate normal densities and equal covariance 
matrices are assumed for each class co;. A training set is used to estimate the mean u; for 
each class and a pooled covariance matrix £ for all classes. A priori probabilities P(o)i) 
are provided as input indicating the relative prevalence of each class. As an example, the 
percentage of normal and abnormal measurements determined by histopathology may be 
used. Posterior probabilities, P(G)J|X), the probability of a measurement vector x 
belonging in class coj, is calculated from the Bayes formula for each measurement in the 
test set and this value is normalized to fall between [0 1]. For the 2 class case, a linear 
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discriminant function is then used to classify the test observations, x, into one of the two 
classes based on comparing the output of the two discriminant functions for / = 1,2 : 
The two discriminant functions are then combined into a single discriminant function 
g(x) = g{(x)- g2(x), 
so that observation, x, is assigned class a>i if g(x) > 0 and assigned to class 002 otherwise. 
If the threshold for the discriminant function is varied, or equivalently, if the decision 
boundary in varied between [0, 1] based on the posterior probabilities calculated from the 
test set, one may construct a receiver-operating characteristic (ROC) curve. 
An ROC curve is a plot of the sensitivity versus 1-specificity for the classifier. 
This is equivalent to counting and plotting the true positives (TP) and false positives (FP) 
as the decision threshold is varied. One can choose a threshold at which to operate the 
classifier. Often this point is chosen to maximize both the sensitivity and specificity. The 
area under the curve (AUC) of the ROC is an often used figure-of-merit (FOM) for 2-
class classifiers. An AUC of .5 indicates no diagnostic performance while an AUC of 1.0 
indicates perfect diagnostic performance. The AUC can be used to evaluate and compare 
the performance of different classifiers. 
A limitation of the linear discriminant classifier is that normal distributions for the 
observations are assumed. If the parameters for the normal distributions are estimated 
from a small training set, this assumption may cause the classifier to poorly generalize to 
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additional new data. Decision trees are a commonly used nonparametric method for 
multiclass classification which help to classify the data in an intuitive manner and make 
no assumptions about the distributions of the observations [62]. Decision trees are 
structured from a collection of nodes connected by branches. Each node 'asks a 
question' concerning the value of a single feature, for example, whether the value of a 
particular feature if above or below a specific threshold. The tree begins with a root 
node. The root node is connected, by branches, to other nodes which eventually 
terminate at leaf nodes where observations are put into a class. For a particular decision 
tree, one must specify how the tree is constructed from the training data, including how 
splits are made (i.e. what feature to use to make new branches), and how to determine 
when to declare leaf nodes. Feature selection is implicit in the construction of the tree as 
a decision needs to be made about which feature to test at each node. 
It is possible to allow the tree to grow until all training data is classified perfectly, 
but this is likely to generalize poorly to new data, especially with small training sets. In 
order to avoid overtraining, a decision tree may be pruned using cross-validation to find 
the smallest tree at which adding further nodes does not statistically decrease the cost of 
the tree. One way to define the cost of the tree is in the zero-one sense, where the cost of 
misclassifying an observation is 1 and the cost of correctly classifying an observation is 
0. 
It is not intuitive to create ROC curves using decisions tree classification methods 
and therefore the AUC criterion is not often used as a FOM for evaluating the 
classification performance. Sensitivity, specificity, positive predictive values, and 
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negative predictive values are commonly used to evaluate decision tree classification 
performance. 
2.5.3 Feature Selection and Resampling methods 
Using an excessive number of features with a small data set may result in 
overtraining a classification algorithm [59,63]. A feature selection algorithm can be used 
in order to determine the most important and diagnostically relevant features which can 
then be used for classification. An important attribute of a feature selection algorithm is 
that it preserves the feature set. This differs from feature extraction methods, such as 
principle component analysis (PCA), which transforms the original feature space in a 
new feature space. 
The feature selection method used in this work is termed a forward sequential 
search (FSS) algorithm. This method starts with an empty feature set and adds features 
one at a time to maximize a specified criterion determined by a mining algorithm until 
some defined threshold or a specified feature set size is reached. This method is not 
exhaustive and risks missing optimal subsets but is much less computationally expensive 
than a complete search which searches all possible combinations of features [64]. 
An example of a criteria which may be used by a FSS algorithm is the area under 
the curve (AUC) of the receiver-operating characteristic (ROC) produced by a classifier. 
This type of criteria is termed a dependent criteria because it is utilizes a mining 
algorithm based on classification accuracy and therefore tends to pick features which 
achieve higher final performance compared to a search algorithm using independent 
criteria such as distance measures or correlation measures [64]. 
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The FSS algorithm works as follows: Starting with a set of one feature, 
classification of the training set is performed with cross-validation utilizing the FSS 
algorithm to find the single feature which produces the most accurate classification. This 
is repeated with two features, then three, four, ect. The optimal number of features is 
determined when adding additional features does not increase the classifier performance. 
This entire procedure may be repeated many times to provide statistically significant 
results. The AUC values from each iteration may then be compared using statistical 
methods to determine when no statistically improvement is achieved by adding additional 
features. Once the optimal number of features is determined, the specific optimal feature 
subset can be determined by selecting the most commonly chosen features. 
Resampling methods are useful for avoiding overly optimistic estimation of 
classifier performance due to overtraining. K-fold cross-validation is a commonly used 
method. It consists of separating an available data set into k, approximately equal sized, 
subsets or folds. 
k-1 folds are then used to train a classification algorithm and the remaining fold is used 
for validation. This is repeated k times so that the validation set is a different fold at each 
iteration. The classifier performance is then averaged over the k-folds to produce a 
performance estimate with minimal optimistic bias [63]. 
20 
CHAPTER 3: A MULTISPECTRAL OPTICAL IMAGING DEVICE FOR IN 
VIVO DETECTION OF ORAL NEOPLASIA1 
3.1 Introduction 
Oral cancer poses a significant world health problem, ranking as the sixth most 
common cancer globally [4], causing over 127,000 deaths worldwide each year [65]. In 
the United States alone, there were an estimated 30,990 cases of oral cancer diagnosed 
and 7,430 deaths in 2006 [3]. Oral cancer often goes undiagnosed until the later stages of 
development, resulting in high mortality. In the United States, the five-year survival rate 
for localized oral cancer is 81%, but this drops to only 30% for advanced disease [66], 
suggesting that early detection has the ability to save many lives. In addition, patients 
who survive an initial occurrence of oral cancer are known to be at an increased risk of 
developing a second malignancy highlighting the importance of continued surveillance of 
this population [67]. 
The most common screening method for oral cancer is visual inspection and 
palpation of the mouth. Physicians inspect for clinically evident oral lesions such as 
leukoplakia (white patches) or erythroplakia (red patches) which are associated with 
increased risk of oral cancer [4,21]. Visual examination relies heavily on the experience 
and skill of the physician to identify and delineate early premalignant and cancerous 
changes. Several benign conditions, such as lichen planus, inflammation and 
hyperkeratosis, mimic the clinical presentation of precancerous lesions, and visual 
1
 This chapter has been published in the following journal article: Darren Roblyer, Sokolov KV, El-Naggar 
A, Williams M , Kurachi C , Gillenwater A, Rebecca Richards-Kortum, "A Multispectral Optical Imaging 
Device for In Vivo Detection of Oral Neoplasia", Journal of Biomedical Optics. 2008 Mar-Apr; 13(2) 
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inspection with standard white light illumination may not yield sufficient contrast 
between normal and abnormal tissues. Once a suspicious lesion is identified, biopsy and 
histological examination is required for definitive diagnosis. Biopsies are invasive, 
painful, costly, and require familiarity and skill, and are therefore typically limited to 
highly suspicious lesions. Additionally, many lesions are heterogeneous in morphology 
and visual appearance, and biopsy diagnosis may not be representative of the entire lesion 
due to the small sampling area [68]. Approaches which can help differentiate between 
normal and neoplastic areas and which can reduce the need for evaluator experience have 
the potential to greatly facilitate and improve early diagnosis of oral cancer. 
Optical imaging has the potential to address these clinical challenges. Contrast 
between normal and neoplastic areas can be increased beyond that which is available 
with standard white light by tuning the illumination and detection conditions. 
Reflectance imaging can detect local changes in scattering and absorption of tissue and 
fluorescence imaging can probe changes in the biochemical composition of tissue by 
revealing levels of endogenous fluorophores. These changes have shown to be indicative 
of malignant progression [55] and are targeted in a variety of imaging modalities to detect 
and diagnose premalignant changes in different anatomic sites including the cervix [50], 
gastrointestinal tract [41], lung [69], and oral mucosa [21,38,44,53,55,70-72]. High 
resolution optical imaging techniques such as confocal microscopy, and optical 
coherence tomography have the potential to image changes in tissue architecture and 
cellular morphology. A drawback to in vivo cellular resolution microscopy however, is 
the small field-of-view (FOV) interrogated, making screening of an entire mucosal 
surface impractical without an initial means of guidance towards suspicious areas. Wide-
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field optical imaging techniques allow clinicians to screen several centimeters at a time 
for identification of margins and optimal sites for further interrogation by small FOV 
imaging techniques or biopsy. 
Several wide-field optical imaging systems have shown promise to improve 
detection of neoplastic lesions in the oral and oropharyngeal regions. Lane et al. 
presented a non-magnifying hand-held device for direct visualization of oral cavity tissue 
fluorescence [21]. The system uses a metal-halide lamp with emission peaks at 405 and 
436 nm to excite tissue autofluorescence. Images obtained using this device showed a 
characteristic decrease of green fluorescence associated with oral precancer and cancer. 
Decreased green fluorescence distinguished normal tissue from severe dysplasia, 
carcinoma in situ, or invasive carcinoma in 50 biopsy sites from 44 patients with a 
sensitivity of 98% and specificity of 100%, using histology as the gold standard. This 
device is available commercially as the VELscope®, which is FDA approved and is 
currently in clinical use. De Veld et al. provide an excellent review of the status of in 
vivo autofluorescence imaging for oral oncology [55]. 
While fluorescence imaging alone has shown great promise for detection of 
neoplastic lesions in the oral cavity, incorporating additional imaging techniques may 
increase the effectiveness and sensitivity of wide-field optical devices. Techniques which 
are capable of detecting increases in vascular density and changes in light scattering 
properties may be particularly useful, since these features have previously been 
associated with the development of cancer, and are not easily detected by fluorescence 
imaging alone [73]. Additionally, reflectance imaging systems tend to be simpler in 
design compared to fluorescence devices, thereby reducing instrument complexity and 
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cost. In narrow band (NB) reflectance imaging, tissue is illuminated using a narrow 
wavelength band (e.g. 10-20 nm) and reflected light is imaged. The optical contrast of 
microvasculature close to the epithelial surface may be increased by selecting an 
illumination band which matches peaks in the absorption spectrum of hemoglobin [74]. 
Another approach to increase contrast is to control the polarization of the illumination 
source and detected light. In orthogonal polarization reflectance (OPR) imaging, tissue is 
illuminated with linearly-polarized light; a second linear polarizer is placed in front of the 
detector and oriented so that only remitted light with a polarization orthogonal to the 
illumination is captured. This has the effect of selectively detecting photons which have 
undergone multiple scattering events in the tissue (resulting in a reduction in degree of 
polarization), and rejecting those singly-scattered photons returning from the surface of 
the tissue. This technique enables observation of deeper or birefringent tissue structures 
and enhances the prominence of microvasculature due to increased hemoglobin 
absorption [75]. When both orthogonal and parallel polarization images are captured, 
they can be mathematically combined to form a composite image which has been shown 
useful for imaging skin pathologies [75]. Lindeboom et al. have described orthogonal 
polarization spectral (OPS) imaging of oral tumor sites using a magnifying handheld 
device coupled to a CCD camera, designed to provide maximum contrast between the 
microvasculature and surrounding tissue [76]. 
The Multispectral Digital Microscope, or MDM, was developed to investigate the 
diagnostic effectiveness of combining multiple imaging modalities in a single device 
compared to measuring reflectance or fluorescence signals alone. The MDM acquires 
high-resolution, wide-field images in vivo, using white light illumination, fluorescence 
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excitation, NB, and OPR modes. The MDM employs a wide range of illumination 
wavelengths to investigate which provides the greatest contrast between normal and 
neoplastic areas for each imaging mode. In this paper, we describe the design of the 
device, evaluate its optical performance, and present sample images obtained in human 
subjects with the MDM system. 
3.2 Materials and Methods 
3.2.1 Instrumentation 
Figure 1 shows an optical schematic of the Multispectral Digital Microscope 
(MDM). The OPMI® pico dental microscope (Carl Zeiss, Jena, Germany) is used as the 
core optical component of the MDM. These is a single objective lens and the 
magnification setting is adjusted by turning a turret to one of five positions. Light is 
routed from the source to the microscope head by a fiber optic light guide. The working 
distance of the microscope is 25 cm. The field of view (FOV) of the device is dependent 
on the choice of magnification setting and ranges between 1 cm and 4 cm in diameter. 
With a monitor size of 17 inches, the system magnification ranges from 8.5 times to 34.7 
times. 
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Figure 1 A. The Multispectral Digital Microscope (MDM) in the 
Head and Neck Clinic at the MD Anderson Cancer Center. B. 
System optical schematic. 
We replaced the original light source with an air-cooled 100 Watt mercury arc 
lamp (Photon Technology International, Birmingham, NJ), housed in a custom light box. 
The lamp and ellipsoidal reflector produce a converging beam which is collimated using 
a 25 mm plano-convex lens (Lambda Optics, Costa Mesa, CA). To protect both the 
patient and optical components from excessive heating, a custom cold mirror (Barr 
Associates, Westford, MA) eliminates unwanted IR radiation from the lamp, and an 
absorbing glass filter removes UV light at wavelengths below 350 nm. The beam then 
passes through a ten-position excitation filter wheel (Sutter Instruments, Novato, CA) and 
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through a second plano-cOnvex lens which focuses the beam onto the proximal face of a 
5 mm diameter fused quartz light guide (Fiberoptic Systems, Simi Valley, CA), which 
routes the light to the microscope head. Since the microscope was not originally designed 
to support near UV excitation, a custom machined adaptor was implemented to bypass 
the original illumination optics and to hold the distal end of the light guide and a fused 
quartz focusing lens (Newport Optics, Stratford, CT). This adaptor provides a significant 
increase in near UV excitation power and subsequently reduces exposure times required 
for fluorescence imaging. The adaptor also holds a linear polarizer (Chroma 
Technologies, Rockingham, VT) which is servo controlled and engaged by the Lab View 
(Austin, TX) interface. 
The illumination filter wheel contains narrow band illumination filters at 420 nm, 
430 nm, 530 nm, and 600 nm for NB imaging. These wavelengths were selected to 
match hemoglobin absorption features, and also to provide multiple wavelengths 
throughout the visible spectrum to study the effects of wavelength on penetration depth. 
The illumination filter wheel also contains narrow band illumination filters at 365 nm, 
380 nm, 405 nm, and 450 nm for autofluorescence excitation. These excitation 
wavelengths were chosen based on previous work by Heinzelman et al. and Utzinger et 
al. [53,77]. The full-width at half-maximum (FWHM) transmission bandwidth for the 
excitation filters ranges from 20 nm for NB imaging, to 50 nm for UV illumination 
(Chroma Technologies, Omega Optics). A 1.0 neutral density filter is used to attenuate 
the white light illumination power. A light-blocking disk occupies one position in the 
excitation filter wheel and is used for measurement of the background light level. 
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Table 2. Irradiance and typical exposure times for each illumination 
condition. 
Illumination 
X (nm) 
365 
380 
405 
450 
white 
420 
430 
530 
600 
white 
polarized 
Imaging 
Modality 
fluor. 
fluor. 
fluor. 
fluor. 
reflect. 
reflect. 
reflect. 
reflect. 
reflect. 
polarized 
Irradiance 
(mW/cm2) 
11.15 
8.86 
7.00 
5.10 
12.02 
3.13 
9.62 
1.91 
4.17 
3.47 
Typical 
Exposure 
(ms) 
100 
160 
400 
500 
16 
64 
13 
24 
64 
100 
The emission arm of the MDM consists of a Zeiss objective lens and 50/25/25 
beam splitter which passes 50% of the emission light to the microscope eyepieces and 
25% each to two CCD detectors. An emission filter wheel (Oriel Optics, Stratford, CT) is 
located in one detection arm and contains longpass filters and a linear polarizer. A 
longpass filter with a 50% transmission at 410 nm is used with the 365 nm and 380 nm 
excitation, one centered at 430 nm is used with 405 nm excitation wavelength, and one 
with a 50% transmission at 475 nm is used with 450 nm excitation. An additional linear 
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polarizer is placed in the opposing detector arm as shown in Figure 1. In one arm, the 
polarizer is oriented parallel to the excitation polarizer and in the other, the polarizer is 
oriented perpendicular. The opposing polarizers allow for simultaneous OPR and parallel 
polarization imaging; this feature is useful for reducing changes in FOV which can occur 
due to patient movement. 
Two Retiga Exi (Qlmaging, Burnaby, BC Canada) 12-bit color cooled cameras 
are used to collect image data. This camera model was chosen because of its low light 
sensitivity and compatibility with the Lab View programming environment. The sensor is 
a Sony ExHAD ICX285 progressive-scan high-sensitivity CCD chip, providing adequate 
spectral sensitivity at chosen wavelengths of interest, from 400 nm to 650 nm. The chip is 
covered by a Bayer Mask mosaic for color imaging. Image data is saved in raw Bayer 
format and color interpolation is performed in post-processing based on color balancing 
standards. 
Control of the MDM system is by accomplished by a custom Lab View graphical 
interface. The interface provides the operator with the ability to image with one 
excitation/emission wavelength pair at a time, or to collect a rapid sequence of image 
data over the range of the MDM's capabilities. The interface also allows the user to store 
information such as study number and patient data which are linked and saved with the 
optical data. Imaging parameters are recorded for all data collected, and background 
measurements are taken with each sequence. 
The MDM takes about one minute to collect a complete image sequence. The 
sequence is composed of white light reflectance, fluorescence, NB, OPR, parallel 
polarization reflectance, and background data sets. A predefined set of exposure and gain 
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settings was established for each image in the sequence based on measurements of 
normal volunteers. In order to account for inter-patient variability, measurement site 
variability, and changes due to disease, the predefined set of exposure times could be 
manually scaled up or down in 20 percent intervals during imaging. Additionally, four 
duplicate images were taken for each illumination/emission setting at lower and higher 
exposure times relative to the initial choice. Table 2 shows typical exposure times based 
on the most commonly used exposure settings used in the pilot clinical trial. 
A set of standards was chosen to quantify the performance of the MDM as well as 
to track any changes occurring in the device over time. Positive reflectance standards 
include 99%, 75%, and 50% reflectance spectralon disks (Labsphere, North Sutton, NH), 
and red, green, and blue portions of a Macbeth Color Chart (GretaMacbeth LLC, New 
Windsor, NY). A 2% spectralon disk serves as a negative reflectance standard. Positive 
fluorescence standards include a set of four fluorescent slides (Microscopy/Microscopy 
Education, microscopyeducation.com) and the negative fluorescence standard is a frosted 
quartz disk (Mark Optics, Santa Ana, CA). 
For white light illumination, color balance was achieved by imaging a white 
balance sheet and adjusting the RGB ratio in software so that equal pixel intensity values 
were obtained in the red, green, and blue channels. For fluorescence imaging, a constant 
color balance was used throughout the study to maximize qualitative diagnostic ability 
and to reflect the natural blue-green tissue fluorescence color. The fluorescence color 
slides were used as a standard to track any changes in color response of the camera over 
time in fluorescence mode. 
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3.2.2 Pilot Clinical Study 
Several sites within the oral cavity of normal subjects were imaged using the 
MDM as part of an IRB approved protocol at Rice University. In a separate, ongoing 
pilot clinical study conducted at The University of Texas MD Anderson Cancer Center 
(MDACC), the MDM was used to image clinically abnormal and normal oral mucosal 
sites in patients. This protocol was approved by the Institutional Review Boards at both 
Rice University and MDACC. 
The measurements were performed either in the outpatient clinic or in the 
operating room on patients under general anesthesia prior to surgery. The areas to be 
imaged were chosen by the clinician and included areas that had previously been 
identified as abnormal by clinical examination and/or biopsy. The physician first 
evaluated these targeted areas using the MDM under white light illumination, adjusting 
the focus and FOV. Several measurement sequences were then taken from each subject 
including abnormal sites, and when possible, a corresponding contralateral normal site. 
Excess saliva was suctioned prior to imaging. Because teeth exhibit particularly strong 
autofluorescence, attempts were made to cover any teeth in the FOV with low-
fluorescence gloves or a mouth guard. The head of the patient was positioned and held by 
the physician during imaging in order to reduce motion artifacts. In patients seen in the 
clinic, biopsies were obtained from clinically abnormal sites and a contralateral normal 
site. In patients who underwent surgical excision, the resected specimens were 
histologically examined. A clinical diagnosis for normal and abnormal-appearing areas 
(graded as normal, abnormal but not suspicious for neoplasia, suspicious for neoplasia, or 
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cancer) was rendered by the clinician. The histopathology diagnosis of biopsy sites and 
resected tissue from imaged areas were considered the gold standard for diagnosis. 
Four observers (DR, CK, AG, RRK) examined the images to identify features that 
differed in abnormal sites compared to clinically normal areas, and which might be 
further explored for diagnostic relevance. Qualitative observations of image data were 
correlated with clinical observations regarding peripheral extent of abnormal changes and 
clinical diagnostic category. Pathology results from resected tissue and biopsies allowed 
comparison between MDM image data and histopathologic diagnosis of lesions. 
3.3 Results 
3.3.1 Instrument Performance 
The resolution of the MDM was determined by imaging a USAF spatial 
resolution target, as shown in Fig. 2. A line spacing of 15.6 um (group 5, element 1) can 
clearly be discriminated at the highest magnification. The appearance of shadowing 
behind each element is due to the finite thickness of the glass substrate, and is not 
intrinsic to the MDM system. Measurements of white light illumination on a 99% 
reflectance spectralon standard (Labsphere, North Sutton, NH) show a 4 cm diameter 
illumination spot size. This is adequate to illuminate all but the edges of the FOV at the 
most commonly used magnification. The illumination pattern is Gaussian due to light 
guide coupling with the highest intensities in the center of the FOV. 
To confirm the absence of excitation filter leakage and adequacy of performance 
of longpass filters, a 2 inch diameter frosted quartz disk was imaged in fluorescence 
mode. Exposure times and gain settings matching or exceeding those used for normal 
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tissue fluorescence imaging were used at each excitation/emission wavelength pair to 
confirm the absence of signal from the non-fluorescent frosted quartz disk. The ratio of 
autofluorescence signal from tissue to frosted quartz was always greater than 10:1. 
Figure 2. A USAF Resolution target imaged at high magnification. 
Element 5 group line spacings are 15.6um (shown in the dashed 
box) are easily discriminated in the zoomed-in image on the right. 
Intra-sequence image registration was affected by patient movement, generally 
causing some changes in the FOV during the course of the image sequence. Figure 4 
shows several images taken from a typical sequence in a clinical setting at the most 
common magnification setting. Using user-defined selection of points common to both 
images, the linear translation was less than 60 pixels (less than 5% of the FOV) between 
any two of the images in the sequence in both the x and y directions. 
UV radiation during all human measurements is well below the American 
Conference of Governmental Industrial Hygienists maximum allowed rating [78]. 
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3.3.2 MDM Images of Normal Oral Sites 
Sites imaged in the oral cavity from four normal volunteers included tongue, 
buccal, lip, gingiva, hard palate, soft palate, and floor of mouth. Fine vasculature was 
clearly identifiable in images acquired from the lip, floor of mouth, hard palate and soft 
palate using white light, NB, OPR and fluorescence techniques. These images serve as 
further examples of the resolution capabilities of the MDM. Figure 3 shows an image of 
the lower lip of a normal volunteer under several illumination conditions. The white light 
image (3A) shows microvasculature from a variety of depths beneath the epithelial 
surface. The OPR image illustrates similar vascular patterns; specular reflection is no 
longer visible in the image, and spatial resolution is somewhat reduced because the OPR 
technique selectively records photons that have undergone more scattering events in the 
tissue. The NB image obtained with 420 nm illumination (3B) shows only the 
superficial, fine vasculature due to the reduced penetration of this wavelength; vessel 
contrast is also increased because this wavelength matches the Soret absorption band of 
hemoglobin. As the illumination wavelength is increased from green (3D) to red (3F), 
vessels deeper within the tissue are visible in the image. The NB image obtained with 
600 nm illumination shows a loss of contrast and spatial resolution due to the increased 
ratio of scattering to absorption and increased mean free path between scattering events at 
this wavelength. Vasculature was not as apparent in the buccal and tongue. 
Tissue autofluorescence is predominantly blue at UV excitation wavelengths (3E) 
and blue-green at the longer 450 nm excitation. The hard palate, soft palate, floor of 
mouth, and buccal mucosa provided a higher fluorescence signal than the tongue, 
gingiva, and lip. The midline of the hard palate was particularly bright. Teeth were 
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highly fluorescent and tooth fluorescence could be seen through portions of the gingival 
mucosa. Blood vessels appeared dark under fluorescence mode compared to the 
surrounding tissue. Red fluorescence occasionally appeared on the dorsal tongue. 
365 nm 11. 600 nm 
Figure 3. Images of normal volunteer inner lip. A. White light 
illumination image. B. 420 nm NB image. C. OPR image. D. 530 
nm NB image. E. 365 nm excited fluorescence image. F. 600 nm 
NB image. Note increased contrast of vasculature in C. compared to 
white light image. Fine vasculature is visible in B., whereas, deep, 
larger diameter vasculature is visible in F. Scale bars indicate 2.5 
mm. 
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3.3.3 MDM Images of Oral Dysplasia and Cancer 
Images of a premalignant lesion and an invasive cancer are presented as 
representative examples to demonstrate the capabilities of the MDM system for 
examination of the oral cavity. Some images were cropped to only show relevant areas. 
Figure 4 shows images obtained from a thin leukoplakia lesion (indicated by 
arrows) on the right mandibular gingiva. The thin leukoplakia in the OPR image (4C) is 
less evident demonstrating the ability of OPR imaging to selectively detect photons that 
have scattered more deeply into the tissue. The blue NB image (4D) shows the 
leukoplakia as brighter in reference to surrounding tissue compared to the white light 
image. 
Figure 5 shows images acquired from a subtle lesion on the right lateral tongue. 
The clinical impression of the lesion was leukoplakia, but not overly suspicious for 
dysplasia or cancer. Following imaging, a 2.4 x 1.0 x 0.4 cm volume was surgically 
resected and histopathology showed moderate squamous dysplasia (Fig. 5H). The 
standard white light image (5A) shows some patchy irregularities in the mucosal surface. 
Using the green NB (5E) and the OPR imaging conditions (5C), an apparent increase in 
visual contrast was observed between the lesion and surrounding normal areas (indicated 
by arrows in each case). A decreased blue/green autofluorescence (DA) was observed in 
the area of the lesion in fluorescence images at 365 nm, 380 nm and 405 nm excitation 
(5B, D, F). An image of a contralateral normal area imaged using white light is shown in 
5G for comparison. 
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Figure 4. Images of leukoplakia lesion on right gingiva. A. White 
light illumination image. Arrows indicate area of leukoplakia. B. 
Parallel polarization image. C. OPR image. D. 420 nm NB image. 
Note that the OPR (C) allows visualization of tissue below the thin 
leukoplakia and the 420 nm OPR image (D) accentuates areas of 
leukoplakia. Scale bars indicate 2.5 mm 
Figure 6 shows images acquired from a premalignant lesion on the left lateral 
tongue. The clinical impression was erythroplakia; a reddish lesion associated with a 
high risk of dysplasia or early carcinoma. Histopathology from a biopsy of the lesion 
indicated severe squamous dysplasia with a focal ulceration and chronic inflammation 
(6H). Both the OPR image (6C) and the green NB image (6E) showed an area of 
abnormality (appearing darker red on OPR and darker on NB images as indicated by 
arrows) which is more extensive in peripheral extent and has increased contrast as viewed 
against the surrounding mucosa. In the images obtained using all four fluorescence 
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excitation wavelengths a comparative decrease or loss of blue or green fluorescence was 
seen in the abnormal site. The total area of DA was larger at 405 nm excitation (6F) than 
at 365 nm (6B) and 380 nm excitation (6D). In addition, a striking ring of increased red 
fluorescence surrounding the lesion was observed in the fluorescence images, and is most 
apparent at 405 nm excitation. This red fluorescence is consistent with the presence of 
endogenous porphyrins. A white light image obtained from a contralateral normal area is 
shown in 6G for comparison. 
Figure 5. Images from tongue of patient with leukoplakia. A-F 
show a FOV containing areas along the lateral aspect of the tongue 
which were resected and found to contain moderate dysplasia. A. 
White light illumination image. B. 356 nm excited fluorescence 
image. C. OPR image. D. 380 nm excited fluorescence image. D. 
530 nm NB image. F. 405 nm excited fluorescence image. G. White 
light illumination image of contralateral normal site. H. H&E 
stained tissue from abnormal area indicating moderate dysplasia. 
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Arrows indicate areas with loss of fluorescence or increased 
contrast. Scale bars indicate 5 mm in A-G and 200 urn in H. 
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Figure 6. Images from ventral tongue of patient with erythroplakia. 
A-F show a FOV of the left lateral tongue containing erythroplakia 
from clinical appearance and severed dysplasia from 
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histophathology of biopsy site. A. White light illumination image. B. 
356 nm excited fluorescence image. C. OPR image. D. 380 nm 
excited fluorescence image. D. 530 nm NB image. F. 405 nm 
excited fluorescence image. G. White light illumination image of 
contralateral normal site. H. H&E stained tissue from abnormal area 
indicating severe dysplasia. Arrows indicate areas with loss of 
fluorescence or increased contrast. Scale bars indicate 5 mm in A-G 
and 200 jxm in H. 
Figure 7 shows images from the right lateral tongue in a subject with 
histologically confirmed carcinoma. A previously biopsied and ulcerative lesion is 
shown in the center of the FOV. In the OPR image (7B), the blue NB image (7C), and 
the green NB image (7C), increased contrast is noted by arrows in the tissue surrounding 
the ulcer. The blue NB image (7C) shows larger dark areas in the ulcerative lesion and in 
the bottom right compared to the white light image (7A). The red NB image (7G) shows 
smaller dark areas compared to white light. The fluorescence images show a decrease of 
blue/green fluorescence surrounding the ulcerative lesion, and this DA is more apparent 
for 405 nm and 450 nm excitation (7F, 7H) than at 365 nm excitation (7ED). Following 
imaging a 3.2 x 2.5 x 1.0 cm3 portion was resected and was determined by histopathology 
to contain invasive squamous carcinoma centrally, with dysplasia near the margins of 
resection. 
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In these representative examples, we observe one or more of the following 
features in areas histologically determined to be abnormal: a decrease of blue/green 
fluorescence, increased red fluorescence, and an increase of contrast in highly vascular 
regions. Blood on the surface of the tissue also appeared dark compared to white light 
under blue and green narrow band illumination. Teeth and gloves occasionally interfered 
with fluorescence imaging of tissue due to their autofluorescence, as can be seen in the 
lower left corner of the fluorescence frames in Figure 5. 
43 
Figure 7. Images from cancer on right lateral tongue. A. White light 
illumination image. B. OPR image. C. 430 nm NB image.. D. 365 
nm excited fluorescence image. E. 530 nm NB image F. 405 nm 
excited fluorescence image. G. 600 nm NB image. H. 450 nm 
44 
excited fluorescence image. Arrows indicate increased contrast or 
decreased autofluorescence. Scale bars indicate 2.5 mm. 
3.4 Discussion 
In this study, DA was observed in many clinically abnormal areas compared to 
surrounding normal tissue, and this finding was common to all four fluorescence 
excitation wavelengths. DA was also observed surrounding submucosal, exophytic or 
hyperkeratotic abnormal areas as well as in clinical lesions lacking the white keratotic 
surface associated with leukoplakia. Areas with DA did not always correspond to areas 
where increased contrast was seen using other modalities. Increased red fluorescence 
was observed in about half the patients imaged to date. It appeared most often on 
cancerous regions and on necrotic tissue but occasionally appeared in clinically 
dysplastic or precancerous areas. Red fluorescence did not usually correlate with DA or 
with increased contrast from NB or OPR imaging. 
Blue and green NB images tended to increase contrast of visible blood vessels and 
areas suspected of containing a high density of superficial microvasculature. Blue 
illumination revealed fine vasculature which appeared superficial whereas illumination at 
green or red wavelengths revealed larger diameter, deeper vasculature. 530 nm 
illumination was most useful in increasing negative contrast in lesions in study patients. 
Blood on the surface of the tissue also appeared dark under blue and green narrow band 
excitation. OPR had the effect of reducing specular reflection and increasing negative 
contrast in some abnormal regions compared to imaging under conventional white light 
illumination. Both OPR and NB appear useful for detecting areas with high 
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microvascular density, and in many cases, the resulting images showed extended margins 
of clinically abnormal areas compared to white light imaging. In most cases, discrete 
vessels were observed in normal contralateral measurements and at the periphery of 
abnormal areas, while diffuse, homogeneous red areas were observed on abnormal 
lesions with flat contours. Elevated lesions in cancerous or precancerous areas often 
obscured vascular detail. 
The characteristic DA associated with neoplasia has been extensively explored to 
determine abnormal areas in previous imaging studies in the oral cavity [21,38,72,79]. It 
has been suggested that a decrease of collagen cross-links and decreased density of 
matrix fibers is the major contributor to loss of green fluorescence; these are important 
features that may be associated to malignant progression. Pavlova et al. and Drezek et al. 
have shown that precancerous cervical tissue exhibits decreased stromal fluorescence due 
to a decreased density of matrix fibers [10]. Lane et al., who used excitation light from 
400 nm to 460 nm, suggest collagen-related DA as a major mechanism enabling contrast 
between the appearance of neoplastic areas and normal tissue using the Velscope® 
[21,80]. 
Increased red fluorescence in the oral cavity is well documented for carcinoma, 
and in previous imaging studies [38,39,70,71], red fluorescence was best observed when 
excited at approximately 410 nm. Inaguma and Hashimoto found the presence of fed 
fluorescence in eighty-five percent of the 78 lesions of oral carcinomas they investigated 
[70]. Ingrams et al. have obtained 90% sensitivity and 91% specificity for the 
discrimination of normal and dysplastic/malignant mucosa using the presence of red 
fluorescence [54]. This red fluorescence is generally attributed to the presence of 
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porphyrins whose origins in biological tissue are disputed. It is unclear whether they are a 
byproduct of abnormal metabolism in tissue or if it is produced by bacteria contaminating 
the surface of the tissue. 
Changes in contrast using NB and OPR have been previously observed in oral 
tissue and are likely due to increased microvasculature density and structure associated 
with malignant transformation. Pazouki et al. have shown an increase in vascularity in 
oral tissue throughout malignant progression [73]. By choosing reflectance excitation 
wavelengths which correspond to hemoglobin spectral features, the narrow band 
reflectance images maximize microvasculature visualization and contrast. Subhash et al. 
used this technique to detect abnormal tissue in the oral cavity. They showed that the 
ratio of two oxygenated hemoglobin dips at 540 nm and 575 nm decreased in excised 
malignant tissue compared to normal [74]. De Felice et al. speculated that observed 
optical changes in the color spectrum observed in bronchopulmonary dysplasia may be 
caused by an altered microvasculature network [81]. Wavelength dependent photon 
penetration depth utilized in narrow band reflectance imaging may also provide useful 
depth dependent diagnostic information. 
OPR techniques enabled us to look deeper into tissue by utilizing the ability to 
reject singly-scattered photons that have retained their polarization state. Photons that 
have had their polarization state altered either by multiple scattering events or by 
birefringent properties of the tissue are selectively detected. This can have the effect of 
providing negative contrast against surrounding tissue when imaging vasculature, and of 
making vasculature networks lying deep to the surface appear visible. Lindeboom et al. 
used orthogonal polarization spectral imaging to observe vascular patterns in patients 
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with oral SCC [76]. They found that in 80% of the cases from ten patients, capillary 
density was increased in tumorous areas and in 90% of the cases, disarrangement of 
capillary morphology correlated with tumorous areas. 
This pilot trial was trial was designed to demonstrate the capabilities of the MDM 
as well as to make preliminary qualitative observations of abnormal lesions in humans. 
Further studies of larger groups of patients is required to determine the utility of each 
imaging technique compared to white light inspection, as well as to determine which 
combinations of techniques afford the most useful predictive information. Contributions 
from inflammation or benign conditions to DA or increased contrast in NB imaging will 
affect the specificity of detection and it will be important to determine these effects. 
Additionally, precise pathology correlations will be key to future studies. Correlations in 
this study were made using histopathologically-diagnosed biopsy or resected tissue data 
which was known to be within the FOV during image collection. Biopsy data provides 
information on only a small fraction of the imaged FOV and represents a limitation of 
this pilot study. Improved techniques for spatial correlation between histopathologic 
sections and image data will be needed in future work. 
The MDM described here can obtain high quality images of the oral cavity using multiple 
imaging modalities. To facilitate comparison between modalities, images were collected 
in rapid sequences from the same field of view. Pilot clinical data indicate that additional 
imaging modalities such as NB and OPR may provide information not available in 
fluorescence mode alone, and may be useful in discriminating precancerous and 
cancerous tissue from normal and benign or inflammatory regions. 
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CHAPTER 4: OBJECTIVE DETECTION AND DELINEATION OF ORAL 
NEOPLASIA USING AUTOFLUORESCENCE IMAGING2 
4.1 Introduction 
Head and neck cancer, including cancers of the oral cavity, currently ranks as the 
sixth most common malignancy in the world. There were more than 270,000 new cases 
of oral cancer reported in 2002 [65]. Approximately 60% of these individuals present 
with stage III or IV disease, and about half will die within five years of diagnosis [7]. 
Screening individuals at risk for oral cancer and its precursors has the potential to 
improve early detection, providing the opportunity to intervene when treatment is most 
effective. In addition, surveillance of patients who have survived their initial oral cancer 
is important to identify local recurrences and second primary oral tumors, which occur at 
a higher rate than for any other tumor [82,83]. 
Conventional oral examination using incandescent white light is the current 
standard of care for screening and surveillance for oral cancer and precancerous lesions. 
The sensitivity of visual examination is limited by several factors including the 
experience and index of suspicion of the examiners. In primary care situations, cases of 
malignancy may be seen rarely and clinicians may have difficulty discriminating the 
sometimes subtle mucosal changes associated with premalignant lesions and early 
2
 This chapter has been published in the following journal article: Darren Roblyer, C. Kurachi, V. 
Stepanek, M. Williams , A. El-Naggar, J. Jack Lee , A. Gillenwater, R. Richards-Kortum, "Objective 
Detection and Delineation of Oral Neoplasia Using Autofluorescence Imaging," Accepted for Publication 
in The Journal of Cancer Prevention Research, February 2008 
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cancers from more common benign inflammatory conditions [84]. Furthermore, it can be 
challenging to delineate the boundaries of neoplastic lesions using conventional oral 
examination making the choice of a biopsy location difficult. 
Several new approaches have been proposed to address the limitations of the 
conventional oral examination, including the use of toluidine blue, brush cytology, 
reflectance visualization after acetic acid application, and illumination with a chemi-
luminescent light source. While useful in certain situations, each of these approaches is 
associated with a high rate of false-positives [84-87]. Recently, several studies have 
demonstrated that autofluorescence imaging may improve the ability to distinguish 
normal from premalignant and malignant oral tissue [21,38,45,51,55,88,89]. When tissue 
is illuminated in the ultraviolet-visible region, a portion of photons are absorbed by 
molecules within the tissue called fluorophores which then emit lower energy photons 
that can be detected as fluorescence from the mucosal surface. Examples of fluorophores 
which produce autofluorescence signals in tissue include NADH and FAD in the 
epithelial layer, and collagen and elastin crosslinks in the stroma [19]. In comparison to 
normal oral tissue, neoplastic lesions are associated with a decrease of green fluorescence 
when excited with ultraviolet (UV) or near-UV light [14,51,55,88] that is attributed to 
decreased signal from collagen crosslinks in the stroma [6]. Increased red fluorescence 
has also been observed by several groups in oral lesions and is frequently attributed to 
porphyrins [90]. Several groups have proposed that this perceived loss of green 
fluorescence and increase in red fluorescence can be useful as a diagnostic aid to help 
detect and diagnose early neoplastic disease in several anatomic sites including the oral 
cavity, bronchus, cervix, esophagus and colon [21,91-94]. In addition, the changes in 
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fluorescence may aid in surgical resection by delineating the extent of neoplastic changes 
beyond the clinically apparent margins [55,88]. 
Recently, the U.S. Food and Drug Administration approved an autofluorescence 
imaging device for early detection of oral neoplasia. The device, marketed as the 
VELscope® (LED Dental, Inc., White Rock, BC, Canada), uses a blue/violet light (400 -
460 nm wavelengths) to illuminate oral tissue and long pass and notch filters to enable 
clinicians to directly visualize fluorescence in the oral cavity [21,88]. The VELscope and 
other proposed fluorescence imaging devices rely on qualitative observations to detect 
and delineate neoplastic oral lesions and therefore reliable screening with these 
instruments necessitates well-defined and standardized image interpretation criteria, and 
appropriate user training. This may not be feasible in many primary care situations. We 
hypothesize that the application of digital image processing techniques to 
autofluorescence imaging of oral tissue will provide the ability to objectively identify and 
delineate the peripheral extent of neoplastic lesions in the oral cavity. This will provide a 
powerful tool in patient care locations where experts are not available or where 
physicians encounter few cases of malignant and premalignant neoplasia. Low-cost 
digital cameras with sufficient sensitivity to record tissue autofluorescence in near real 
time are now readily available [95], making clinical application of such automated image 
processing feasible. 
The primary goal of the present study was to evaluate the use of quantitative 
autofluorescence imaging for the detection and delineation of oral neoplastic lesions. We 
demonstrate that a simple, objective method can be used to accurately classify regions of 
interest within an autofluorescence image with 100% sensitivity and 91.4% specificity 
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relative to histopathology. This method can delineate the presence and extent of 
neoplastic lesions within a field of view and provide results which correlate with the 
histopathologic assessment of extent of disease. Thus, quantitative autofluorescence 
imaging may provide a nOn-invasive and objective method to improve screening and 
margin delineation of oral cancers and precancers. 
4.2 Methods 
4.2.1 Human Subjects 
Study subjects were enrolled in a clinical protocol reviewed and approved by the 
Internal Review Boards at The University of Texas MD Anderson Cancer Center and 
Rice University. Patients were eligible and recruited if they were 18 years of age or 
older and had known or suspected precancerous or cancerous squamous lesions located in 
the oral mucosa. Patients may have had previous surgical, radiation, or chemotherapeutic 
treatments. Normal volunteers were eligible and recruited if they were 18 years of age or 
older and had no history of oral pathology. All subjects enrolled in the study gave 
written informed consent. The average age of patients in this study was 59. 42% of the 
patients were female and 58% were male. The average age of normal volunteers in this 
study was 27.4. 27% were female and 73% were male. 
4.2.2 Imaging Procedure 
Autofluorescence images were obtained from the oral cavity of 56 patients with 
clinically abnormal lesions and 11 normal volunteers. Data were divided into a training 
set and a validation set. Data acquired from the first 39 patients and 7 normal volunteers 
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imaged between June 2006 and January 2008 were allocated to the training set and used 
to develop an algorithm for detection of neoplasia. Data acquired from the subsequent 17 
patients and 4 normal volunteers imaged between March and June 2008 formed a 
validation set and were used to test the performance of this algorithm relative to 
histopathology. 
White light and autofluorescence images were obtained at 365 nm, 380 nm, 405 
nm, and 450 nm excitation using a Multispectral Digital Microscope (MDM). This 
device is described in detail elsewhere [96] but briefly, the MDM is a wide-field optical 
microscope which collects digital autofluorescence and reflectance images with a color 
CCD camera from a variable field of view, ranging in size from approximately 1 to 7 cm. 
Patients were imaged either in an outpatient clinic or in the operating room under general 
anesthesia prior to surgery. A physician positioned the patient and microscope so that the 
suspicious lesion or area of interest was clearly in the field of view of the device. 
Clinically normal areas distant from or contralateral to the lesion were also imaged. 
Following imaging in the clinic, suspicious lesions were biopsied. In the operating room, 
previously biopsied lesions were surgically resected. 
4.2.3 Histopathologic Correlation 
Biopsies and resected tissues were evaluated using standard histopathologic 
analysis by a board certified pathologist (either AEN or MDW). The location of 
biopsies and resected lesions was recorded using digital photography so that pathology 
results could later be correlated to multispectral imaging results. In addition, the 
locations of gross anatomical features were noted in both autofluorescence images and 
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histology specimens to aid in correlation. The resulting histopathology sections were 
evaluated to provide a diagnosis along the entire length of the epithelium, also noting any 
submucosal abnormalities in each slide. Histopathology diagnosis included the following 
categories: normal, mild dysplasia, moderate dysplasia, severe dysplasia/carcinoma in 
situ, and invasive carcinoma. For the purposes of diagnostic algorithm development, two 
major categories were defined: normal tissue (including inflammation and hyperplasia) 
and neoplastic tissue (including dysplasia, carcinoma in situ and cancer). 
4.2.4 Analysis and Statistical methods 
Images were preprocessed to subtract signal from ambient room light and 
translated so that white light and fluorescence images of the same field of view were 
spatially registered. 276 measurements corresponding to 159 unique regions of interest 
(ROIs) sites of clinically normal and suspicious regions of tissue were selected from 
white light images by a head and neck surgeon (AMG) blinded to the results of the 
autofluorescence imaging. In some cases, repeat measurements were obtained from the 
same ROI site to help ensure image data was collected without motion artifacts; often 
both the first and repeat measurements were included in the analysis. These repeat 
measurements account for the difference between the number of measurements and the 
number of ROI sites. Heterogeneity in pathologic diagnoses may occur within relatively 
small areas of diseased oral mucosa [68,97] so ROIs were stringently selected from 
suspicious areas using one of following four criteria: 1) areas corresponding to the same 
size and location as a biopsy with a pathological diagnosis, 2) ROIs from locations 
which could be correlated to a histopathology slide with a corresponding pathological 
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diagnosis, 3) areas within well-defined exophytic tumors confirmed by pathological 
diagnosis and 4) ROIs from a location which was clinically normal and deemed by the 
physician to be sufficiently distant from the lesion. 
Autofluorescence images from the training set were analyzed to determine 
whether specific image features could be used to classify a measurement site as normal or 
neoplastic. The autofluorescence images and white light images were spatially registered 
so that the ROIs chosen in the white light images corresponded to the same region of 
tissue in the autofluorescence images. The training set included data from the first 39 
patients and 7 normal volunteers and included measurements from 173 measurements 
from 102 unique ROIs. Qualitatively, neoplastic ROIs were associated with a decrease in 
average green fluorescence intensity and often an increase in red fluorescence intensity. 
The mean ratio of red-to-green pixel intensities inside each of the ROIs was calculated 
from the fluorescence images at each excitation wavelength. Red and green pixel 
intensities were obtained from the collected Red-Green-Blue color images, created by the 
Bayer color mask on the CCD detector. A classifier was developed to distinguish 
neoplastic and normal ROIs using linear discriminant analysis with the single input 
feature of average ratio of red-to-green fluorescence. When more than one measurement 
corresponded to a ROI site, the mean of the feature values was used for classification. 
The classifier was trained using all of the ROI sites in training set and the prior 
probability input into the classifier was chosen to represent the percentage of abnormal to 
normal measurements in the data set. The classifier was developed after images were 
acquired from patients in the training set but before measurements were acquired from 
patients in the validation set. Classifier accuracy in the training set was assessed by 
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plotting the receiver operating characteristic (ROC) curve, the area under the ROC curve 
(AUC), and the sensitivity and specificity at a particular operating point on the ROC 
curve [59,63,98]. The positive and negative predictive values were also calculated at the 
operating point. Confidence intervals were calculated for operating characteristics using 
the Wilson 'score' method including a continuity correction [99]. 
The algorithm was then applied to data from the validation set using the red-to-
green ratio threshold found to produce the highest combination of sensitivity and 
specificity in the training set. The validation set was designed to rigorously test the 
algorithm and for most patients, ROI and biopsy pairs were collected on the clinical 
margins of the lesion in addition to directly on the lesion and in clinically normal areas. 
The validation set included 103 measurements from 57 unique ROIs in a second group of 
17 patients and 4 normal volunteers. 
An additional analysis step was explored to increase the performance of the 
classifier by normalizing the red-to-green ratio measurements for each patient. An 
additional unique and non-overlapping ROI of clinically normal tissue was chosen from 
the same anatomical site and in the same field of view for each of the ROIs described 
above. At each excitation wavelength, the mean red-to-green autofluorescence ratio was 
calculated in this ROI; the mean red-to-green ratios from the other ROIs were normalized 
by this value. This method provides a way to compensate for anatomical and patient to 
patient variations in red-to-green fluorescence intensity ratio. Identical statistical analysis 
was performed using this measured feature with both the training set and the validation 
set. The method utilizing the magnitude of the red-to-green fluorescence intensity ratio is 
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termed the raw red-to-green method and the method utilizing a normalized red-to-green 
fluorescence intensity ratio is termed normalized red-to-green method. 
4.2.5 Disease Probability Maps 
The classification algorithms described above provided a relationship between the 
magnitude of the red-to-green fluorescence intensity ratio for a particular region of 
interest within the image and the probability of that region having a diagnosis of 
abnormal. This relationship was used to predict the probability of a diagnosis of 
dysplasia or cancer for each pixel in an image, given the red-to-green fluorescence 
intensity ratio at that pixel. The posterior probability values at each pixel in the image 
were computed and pixels which corresponded to a 50% or greater probability of being 
classified as dysplastic or cancerous were color coded and digitally overlaid onto the 
white light images. This method provides a means to illustrate areas of tissue with the 
highest probability of being neoplastic. The assumption was made that the region of 
interest method described above could be generalized on a pixel by pixel basis. Disease 
probability maps were compared to histologic images of tissue resected from the field of 
view to confirm the accuracy of this method. 
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Table 3. Anatomic sites of ROIs in the training and validation set. 
Note: Percentages may not add up to 100 % because of rounding. 
Anatomical Site 
Tongue 
Buccal mucosa 
Floor of mouth 
Gingiva 
Lip 
Palate 
Total 
No. of sites in 
training set (%) 
37 (36.3) 
12(11.8) 
22 (21.6) 
2 (2.0) 
14(13.7) 
15 (14.7) 
102(100) 
No. of sites in 
validation set (%) 
19(33.3) 
15 (26.3) 
4 (7.0) 
7(12.3) 
4 (7.0) 
8(14.0) 
57(100) 
Table 4. Pathology diagnosis of ROI sites in training and validation 
set. 
Diagnosis 
Normal 
Mild dysplasia 
Moderate dysplasia 
Severe dysplasia/CIS 
Invasive carcinoma 
Total 
No. of sites in 
training set (%) 
53 (52.0) 
11(10.8) 
6(5.9) 
12(11.8) 
20 (19.6) 
102 (100) 
No. of sites in 
validation set (%) 
35 (61.4) 
5 (8.8) 
4 (7.0) 
6(10.5) 
7(12.3) 
57(100) 
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4.3 Results 
Tables 3 and 4 summarize the anatomic site and histopathologic diagnoses of the 
159 sites included in this analysis. The most common sites were tongue, buccal mucosa 
and floor of mouth, followed by palate, lip, and gingiva. The training set contained 52% 
normal, 28% dysplastic, and 20% invasive carcinoma sites while the validation set 
contained 61% normal, 26% dysplastic, and 12% invasive carcinoma sites. The normal 
histopathologic category could include tissue with hyperkeratosis, hyperplasia, and/or 
inflammation as long as there was no dysplasia or carcinoma. The normal sites in the 
training set, based on available pathology (not including normal volunteers and normal 
sites where no biopsy was taken), included 7 sites (13.2% of normal sites) with 
hyperplasia and hyperkeratosis, 4 sites (7.5% of normal sites) with hyperkeratosis, and 3 
sites (5.7% of normal sites) with hyperplasia and/or fibroadipose tissue. The validation 
set included 3 sites (8.6% of normal sites) with hyperplasia and hyperkeratosis, 1 sites 
(2.9% of normal sites) with hyperplasia, 1 site (2.9% of normal sites) with a submucosal 
hemorrhage, and 1 site (2.9% of normal sites) with marked inflammation and 
osteonecrosis. The abnormal histopathology category could include dysplasia and 
carcinoma. In the training set 59.2% of the abnormal sites were premalignant (mild, 
moderate, or severe dysplasia), in the validation set 68.2% of the abnormal sites were 
premalignant. 
Figure 8 shows white light and autofluorescence images from the buccal mucosa 
of a patient with pathologically confirmed invasive carcinoma. The white light image 
(Fig. 1 A) shows two ROIs, one which corresponds to a pathologically confirmed invasive 
carcinoma, and the other which was clinically normal and outside of the pathologically 
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confirmed clear resection margin. Figures 8B-8D show autofluorescence images at 
different excitation wavelengths that were taken before surgery from the same field of 
view. The autofluorescence image obtained at 405 nm excitation qualitatively shows the 
greatest visual contrast between the normal and neoplastic ROI. This observation was 
typical for study patients. 
Figure 8. Autofluorescence and white light images of the buccal 
mucosa of a typical study patient. A. White light image showing 
regions of interest of histopathologically confirmed normal tissue 
and invasive carcinoma. B. Fluorescence image at 365 nm 
excitation. C. Fluorescence image at 405 nm excitation. D. 
Fluorescence image at 450 nm excitation. 
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Table 5 summarizes the performance of both diagnostic algorithms, based on 
either the raw or the normalized mean red to green fluorescence intensity ratios, for 
classifying lesions in the training set. At each excitation wavelength, the classifier that 
used the normalized red-to-green fluorescence intensity ratio (Normalized R/G ratio) had 
slightly higher AUC than the algorithm based on the raw red/green fluorescence intensity 
ratio (Raw R/G ratio). In all cases, the highest AUC was obtained at 405 nm excitation. 
The sensitivity and specificity values at the point on the ROC curve nearest the gold 
standard (Q-point) are also reported in Table 5. 
Table 5. Classification results at each fluorescence excitation 
wavelength using both the Raw R/G Ratio method and the 
Normalized R/G ratio method in the training set. 
Fluorescence 
excitation 
wavelength 
365 nm 
380 nm 
405 nm 
450 nm 
AUC 
.799 
.871 
.966 
.887 
Raw R/G ratio 
Sensitivity (%) 
91.1 
75.9 
89.3 
83.9 
Specificity (%) 
60.7 
83.6 
95.1 
82.0 
AUC 
.858 
.902 
.982 
.897 
Normalized R/G ratio 
Sensitivity (%) 
79.5 
84.0 
93.8 
84.0 
Specificity (%) 
86.9 
88.5 
95.1 
90.2 
A scatter plot of the normalized red-to-green ratio at 405 nm excitation for each of 
the 102 sites in the training set, as well as the threshold of 1.19 used in the classification 
algorithm is shown in Figure 9A. Of the 102 sites, 4 were misclassified including one 
site of fibroadipose tissue on the lower lip misclassified at abnormal, one hyperkeratotic 
site on the right buccal misclassified at abnormal, one cancer site on the right lateral 
tongue misclassified as normal, and one site on the left soft palate with focal ulceration 
61 
and dysplasia misclassified as normal. Figure 9B shows the ROC curve for this classifier; 
the AUC is 0.988, and at the Q-point, the sensitivity is 95.9% (95% confidence interval 
(CI) 84.9% - 99.3%) and the specificity is 96.2% (95% CI 85.9% - 99.3%). The positive 
predictive value is 95.9% (95% CI 84.9% - 99.3%) and the negative predictive value is 
96.2% (95% CI 85,9% - 99.3%). This operating point is indicated on the ROC curve. 
The algorithm using the normalized red-to-green fluorescence intensity ratio at 
405 nm excitation was applied to the validation set. In Figure 9C a scatterplot of the 
normalized R/G ratio for each site in the validation set is shown along with the threshold 
that had been previously selected for the training set. Figure 9D depicts the ROC curve 
with the operating point selected for the training set indicated. A 100% sensitivity (95% 
CI 81.5% - 99.6%) and 91.4% specificity (95% CI 75.8% - 97.8%) and an AUC of .987 
were achieved at this operating point for the validation set. The positive predictive value 
is 88.0% (95% CI 67.7% - 96.9%) and the negative predictive value is 100% (95% CI 
86.7% - 99.7%). Of the 57 sites in the validation set, 3 were misclassified as abnormal 
including one site on the left buccal with hyperplasia, one site on the right buccal, and 
another site on the left buccal. 
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Figure 9. A. Scatter plot of normalized red-to-green ratios at 405 nm 
excitation for the 102 ROI sites in the training set. The horizontal 
line indicates the threshold used to obtain 95.9% sensitivity and 
96.2% specificity. Note that 2 additional abnormal data points had a 
red-to-green fluorescence intensity ratio greater than 3 but are not 
shown on this plot. B. Receiver-operating characteristic (ROC) 
curve of the classifier based on the normalized red-to-green ratio. 
The operating point used for classification is indicated by a dot and 
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arrow. C. Scatter plot of the red-to-green ratio for the 57 sites in the 
validation set with threshold selected from the training set indicated. 
Note that 3 additional abnormal data points had a red-to-green 
fluorescence intensity ratio greater than 3 but are not shown on this 
plot. D. ROC curve obtained for the validation set. The operating 
point is indicated and corresponds to the threshold chosen from the 
training set. 
Figure 10 shows white light and 405 nm excited autofluorescence images from a 
study patient with moderate dysplasia and carcinoma in situ located in the floor of mouth. 
The white light image is also shown with an overlay of the calculated disease probability 
map; regions corresponding to a predictive probability of a neoplastic lesion greater than 
50% are shaded as indicated by the color bar. The disease probability map indicates the 
probability that a particular pixel in the image corresponds to a neoplastic area of tissue. 
Histologic sections obtained at six areas in the tissue are also shown. Only one of these 
areas was included in the previous classification analysis. The disease probability map 
shows qualitative agreement with the presence of dysplasia and cancer in the areas 
corresponding to the histologic sections. 
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Figure 10. A. White light image of floor of mouth with 
histopathologically confirmed dysplasia and carcinoma in situ. B. 
405 nm excitation fluorescence image showing areas with deceased 
autofluorescence. C. White light image with disease probability 
map showing the predictive probability of a neoplastic lesion 
superimposed. Letters indicate specific locations were pathology is 
known. The key to the right of C. indicates pathology. The 
histology slides below show tissue sections from these areas. 
Marking bar at the lower right-hand corner = 1 mm. 
Figure 11 shows representative white light images with and without superimposed 
disease probability maps from four study patients. Images in the first three rows 
correspond to patients with histologically confirmed neoplasia, while the image in the 
bottom row is from a normal volunteer with no clinically suspicious lesions. Although 
the lesion in Figure 11A is obvious, those in Figures B and C are less so, highlighting the 
potential to aid clinicians in identifying the presence of neoplasia and identifying optimal 
sites for further evaluation with biopsy. Images in Figures 11A and B are from a patient 
with an invasive carcinoma in the floor of mouth. Images in Figures 11C and D are from 
a patient with a region of severe dysplasia on the tongue. The images in Figures 1 IE and 
F are from a patient with a region of moderate dysplasia on the gingiva. In all three 
cases, the disease probability map delineates the suspicious regions identified clinically 
by an oral cancer specialist blinded to the results of the autofluorescence imaging and are 
consistent with histopathologic sections obtained. Figures 11G and H are from the inner 
lip of a normal volunteer and the disease probability map does not indicate any lesions. 
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Figure 11. A. and B. show images from a patient with an invasive 
carcinoma in the floor of mouth. A. White light image B. White 
light image with disease probability mapping showing the predictive 
probability of a neoplastic lesion. C. and D. show images from a 
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patient with a region of severe dysplasia on the tongue. E and F 
show images from a patient with a region of moderate dysplasia on 
the gingiva. G. and H. show images from inner lip of a normal 
volunteer. 
4.4 Discussion 
Our results illustrate how autofiuorescence imaging may enhance the ability of 
clinicians to detect and delineate areas of oral dysplasia and carcinoma. Although all four 
illumination conditions tested allowed visualization of changes in autofiuorescence with 
neoplasia, illumination with 405 nm wavelength produced the highest discriminatory 
capability. This corresponds to previous findings comparing illumination wavelengths 
for autofiuorescence imaging in freshly resected oral cancer surgical specimens [14]. 
While subjective interpretation of loss of autofiuorescence has been shown to be useful 
[21,88], there are several important advantages associated with objective and quantitative 
analysis of changes in autofiuorescence signal. First, quantitative analysis methods 
provide a rigorous and repeatable way to determine the threshold for demarcating a 
lesion, even for providers with less experience. Second, digital imaging allows the 
operator to save and process images, directly comparing data from multiple patients in a 
series or from a single patient over time. Third, ratios of fluorescence intensity values 
provide a way to reduce variations in images associated with spatial non-uniformities in 
illumination. 
In the present study, the performance of a simple classifier based on the ratio of 
red-to-green autofiuorescence intensity at 405 nm excitation was tested and found to 
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discriminate neoplastic and non-neoplastic tissue with a sensitivity and specificity of 96% 
in the training set and 100% sensitivity and 91.4% specificity in the validation set. These 
results compare favorably with the performance of visual oral examination, which has 
been systematically reviewed by Downer et al [22]. Downer identified eight prospective 
studies between 1980 and 2002 that involved conventional oral exam with gold standard 
verification provided by an expert observer. In four of the studies the screeners were 
general dentists and in four of the studies the screeners were trained health workers. 
Sensitivity ranged from 59% to 97%, specificity ranged from 75% to 99%, and meta-
analysis resulted in a weighted pooled sensitivity of 85% and a specificity of 97%. Other 
reports of the performance of visual oral screening include Sankaranarayanan et al 
(sensitivity 77%, specificity 76%) [23], Ramadas et al (sensitivity 82%, specificity 85%) 
[24], and Nagao et al (sensitivity 92%, specificity 64%) [25]. The classifier in this study 
can be applied to entire images of the oral cavity to visualize areas with a high probability 
of being neoplastic; disease probability maps are consistent with histologic sections 
obtained from tissue in the field of view. 
Autofluorescence imaging has shown great promise for enhancing visualization of 
neoplastic areas in recent studies [14,21,38,45,55,88] . In a study of 44 patients, Lane et 
al. demonstrated high sensitivity and specificity at discriminating normal oral mucosa 
from severe dysplasia, carcinoma in situ, or invasive carcinoma based on visual 
assessment of loss of autofluorescence in diseased mucosa at excitation wavelengths 
between 400 nm and 460 nm [21]. In another study by the same group, the potential for 
autofluorescence imaging to enhance delineation of the margins of neoplastic changes 
was demonstrated. In some cases fluorescence loss extended as far as 25 mm beyond the 
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clinically apparent margin [88]. Autofluorescence endoscopic imaging technologies for 
lung and the GI tract utilizing ratios of red and green signal have been available for over 
a decade and have greatly increased sensitivity of disease detection in these organ 
systems [41,91,100,101]. The LIFE™ (laser induced fluorescence emission) system is an 
autofluorescence bronchoscopy device which provides the user with a real time image in 
which changes in hue correspond to suspicious and/or abnormal areas. Users of the 
device must be trained in order to interpret these changes in image hue [100]. 
A potential confounding factor which may limit specificity of classifiers based on 
the red-to-green fluorescence intensity ratio for automated image analysis software is the 
frequent presence of red fluorescence on normal papillae of the dorsal aspect of the 
tongue. At 405 nm excitation, increased fluorescence above 600 nm emission has been 
observed in oral lesions and is thought to originate from porphyrins, although it is 
uncertain whether the origins of these porphyrins are intrinsic or derived from bacterial 
contamination [70]. Red porphyrin-like fluorescence has been shown to correlate with 
neoplastic disease in other regions of the oral cavity [55,70]. However, normal red 
fluorescence is limited to the dorsal tongue; it is not observed on normal areas on the 
lateral and ventral tongue where there is a much higher propensity for developing 
neoplastic disease [102]. In this study, a single site in the training set was imaged on the 
dorsal tongue and corresponded to cancer. Bright red fluorescence was visible at this 
site. 
Our results demonstrate the potential of quantitative fluorescence imaging as an 
objective approach to non-invasively identify and delineate the mucosal extent of 
neoplastic lesions in the oral cavity. It should be noted that the images were obtained 
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with a reSearch-grade device and the disease probability maps described here were 
constructed subsequent to the image acquisition and compared to only a limited number 
of sites with diagnosis confirmed with histopathology. Unfortunately, it is difficult to 
obtain pathology diagnosis for the entire surface of a resected specimen. Additionally, in 
order to provide optimal benefit to clinicians both for detection and margin delineation of 
oral dysplasia and carcinoma, these disease probability maps need to be available to view 
in real or near real-time. We are currently making software improvements and developing 
quantitative fluorescence imaging devices that can show false color disease-probability 
maps based on red/green fluorescence intensity ratios at 405 nm excitation at the time of 
the examination. In addition, we recognize that our results were obtained from a small 
group of subjects with disease prevalence that might be expected in a treatment 
population rather than a screening population. Future studies are planned to evaluate this 
method of quantitative fluorescence imaging in community settings in a larger subject 
group with a wide spectrum of oral pathologies including oral dysplasia and early 
invasive disease, benign conditions and inflammation. 
In summary, the present study provides proof-of-principle for the use of a 
practical tool for the quantitative fluorescence imaging as an objective technique for 
detection and delineation of oral neoplasia. The use of objective disease probability maps 
represents an important advance toward integration of optical imaging technologies into 
the clinical practice of dentists and primary health care workers. Development of non-
invasive and objective diagnostic aids based on these findings may facilitate early 
detection and diagnosis of oral cancer and its precursors by less experienced personnel at 
the point of care. 
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CHAPTER 5: COMPUTER AIDED DIAGNOSIS OF ORAL CANCER AND 
PRECANCER USING MULTISPECTRAL WIDEFIELD OPTICAL 
IMAGING3 
5.1 Introduction 
There is an important need to improve the ability to identify and delineate the 
presence and extent of precancerous oral lesions and cancers so that they can be 
adequately treated [7,68,82,83]. Multispectral widefield imaging is emerging as an 
attractive, non-invasive means to visualize the mucosal surface at risk and identify early 
oral cancer and precancers. Direct autofluorescence visualization has been shown to 
reveal biochemical changes associated with oral precancer and cancer 
[6,21,38,39,42,44,51,87,89]. Reflectance imaging, including narrowband illumination 
imaging and polarized imaging, has been shown to aid in visualizing vasculature in the 
oral cavity [74,76] which increases during malignant progression [73]. It is important to 
identify the imaging modalities, illumination and collection conditions, and/or 
combinations of modalities which provide the most useful diagnostic information. This 
information is valuable both for direct visualization of the tissue with multispectral 
devices and for computer aided diagnosis of lesions based on multispectral digital 
images. 
3
 The content for this chapter is being prepared for publication for the journal IEEE Transaction On Medical 
Imaging. The following authors have contributed: Darren Roblyer, Cristina Kurachi, Vanda Stepanek, 
Richard A. Schwarz, Michelle D. Williams, Adel K. El-Naggar, J. Jack Lee, Ann M. Gillenwater, Rebecca 
Richards-Kortum. 
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An important goal of multispectral optical imaging is to increase the visual 
contrast between normal and neoplastic tissue beyond that available using conventional 
white-light screening techniques. Several studies have shown that illuminating tissue 
with blue light and viewing the autofluorescence from the tissue enhances the ability to 
visually identify neoplastic lesions based on loss of autofluorescence [14,21,55,88]. 
While these results are encouraging, to date, only qualitative observations of image 
contrast between normal and neoplastic oral lesions have been reported; quantitative 
assessment across multiple modalities is needed to optimize performance. 
Computer aided diagnostics (CAD) have been successfully implemented to aid 
automated diagnosis in a variety of organ systems including the prostate [103], pancreas 
[104], cervix [56], liver [105], bladder [106], skin [107], and ovary [108]. CAD 
techniques have been previously applied to analyze white light images of the oral cavity 
to discriminate oral lichenoid reactions and luekoplakia and to segment these lesions 
based on color and morphologic features [109,110]. Our group has previously 
demonstrated that the normalized ratio of red-to-green autofluorescence intensity at 405 
nm excitation is useful to objectively discriminate normal oral tissue and dysplastic and 
cancerous lesions [111]. 
The goals of this study were twofold. The first was to quantify and compare 
optical image contrast available using autofluorescence, narrowband reflectance, and 
cross polarized reflectance imaging modalities for neoplastic lesions in the oral cavity. 
Results of this analysis can help guide the choice of imaging modalities and 
illumination/collection wavelengths for visual examination to detect neoplastic oral 
lesions. The second goal was to develop and evaluate computer aided diagnostic 
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algorithms to detect neoplastic lesions from analysis of multispectral images of the oral 
cavity. Results will aid in determining the modalities and features which contain the 
most diagnostic information and will inform the design and construction of new imaging 
devices for objective diagnosis and delineation of neoplastic oral lesions. 
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Normal Severe Dysplasia 
Feature Normal Severe Dysplasia 
White light Michaelson Contrast 
White light Red to Green Ratio 
NB 530 nm Michaelson Contrast 
405 nm Michaelson Contrast 
405 nm Red to Green Ratio 
Cross Michaelson Contrast 
.048 
1.01 
.052 
.017 
1.02 
.026 
.13 
1.08 
.091 
.37 
1.23 
.095 
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Figure 12. A., C , E., and G. are white light, narrowband 530 nm 
reflectance, 405 nm excitation autofluorescence, and cross polarized 
images of the palate of a normal volunteer. Approximate ROIs are 
shown. B., D., F., and H are images from the palate of a patient 
with severe dysplasia. ROIs of the biopsy location and a 
corresponding clinically normal area are shown. Several feature 
values from these images, computed from the indicated ROIs are 
shown in the table. 
5.2 Methods 
5.2.1 Instrumentation and Data Acquisition 
Widefield images were collected in four different modalities from patients and 
normal volunteers using a Multispectral Digital Microscope (MDM) [96]. The MDM 
consists of a commercially available surgical microscope modified to capture digital 
images in white-light reflectance, autofluorescence, narrowband reflectance, and cross 
polarized imaging modalities. Autofluorescence images were acquired at four different 
excitation wavelengths: 365 nm, 380 nm, 405 nm, and 450 nm. Narrowband reflectance 
images were acquired using illumination wavelengths of 430 nm and 530 nm. In a subset 
of patients, narrowband reflectance images were also acquired at 575 nm illumination. 
White-light reflectance and cross polarized white-light reflectance images were also 
captured. Cross polarized polarization reflectance imaging is achieved by illuminating 
the tissue with linearly-polarized light and collecting remitted light through a second 
linear polarizer, oriented orthogonal to the illumination polarization. In total, there were 
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9 image types which could be collected by the MDM, accounting for the different 
excitation or illumination wavelengths in each modality. 
The MDM captures images of tissue with a rectangular field-of-view of 
approximately 5 X 7 centimeters. The CCD camera utilizes a Bayer mask to collect color 
images. Images are collected as 12-bit RGB tiff files. Camera integration times and gain 
settings were standardized for each subject so that quantitative intrapatient image analysis 
could be performed. 
In this study, the MDM was used to acquire images from patients with 
pathologically confirmed oral lesions and normal volunteers with no history of oral 
lesions, under a protocol reviewed and approved by the Institutional Review Boards at 
Rice University and the University of Texas MD Anderson Cancer Center. Each 
measurement sequence consisted of a serial collection of the aforementioned image types. 
One or more measurements were taken from each study participant, at the lesion site and, 
when possible, at contralateral or distal clinically normal sites. To ensure that high 
quality measurements were obtained, measurements of sites were usually repeated one 
time. 
For purposes of algorithm development and evaluation, data were divided into a 
training set and a validation set. Data from the training set were collected prior to the 
validation set. 
5.2.2 Preprocessing 
Images were collected in vivo and there was often some subject movement 
between image capture of different image types. To account for this, image registration 
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was performed for each measurement sequence. An affine transformation was used to 
translate all of the images taken in a sequence to the white-light base image using up to 8 
common reference points chosen manually. 
Regions of Interest (ROIs) corresponding to normal and neoplastic areas were 
chosen from the white-light images by an expert physician (AG) blinded to the other 
image types. These ROIs were chosen to correspond to one of the following three 
categories: (1) a histopathologically confirmed lesion, (2) a histopathologically confirmed 
non-neoplastic region, or (3) a clinically determined normal region either from a normal 
volunteer or determined by expert physician (AG) to be sufficiently distal to a lesion in a 
patient. ROIs were the approximate size of a 2 mm circular biopsy if biopsy was used for 
histopathology and for clinically determined normal areas, and were the surgical lesion 
size if surgical tissue resection occurred. For each patient, an additional clinically normal 
ROI was selected; image data from these ROIs were used to explore whether normalizing 
data from the aforementioned ROIs to account for interpatient variability could increase 
image contrast and/or diagnostic performance. These normalization ROIs were selected 
either from the contralateral anatomic site or from an area which was sufficiently distal 
from any lesion on the same anatomic site. 
5.2.3 Optical Image Contrast 
The optical image contrast between histopathologically determined lesions and 
normal tissue was calculated and compared for each image type. The contrast was 
computed from ROIs chosen from lesions with a pathologic diagnosis of dysplasia or 
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cancer relative to the corresponding clinically normal ROI. Grayscale versions of the 
collected images were used to compute the contrast. 
Several methods have been proposed to compute image contrast [112,113]; in this 
study we explored four different contrast metrics. Simple contrast was calculated as the 
ratio of the mean grayscale pixel values from the abnormal and normal ROIs. Difference 
contrast was calculated as the difference between the mean grayscale pixel value from the 
abnormal and normal ROIs. We calculated the Weber contrast as the mean grayscale 
pixel value from the abnormal ROI divided by the sum of the mean grayscale pixel 
values from the abnormal and normal ROI. Michaelson contrast was calculated as the 
difference divided by the sum of the mean grayscale pixel values from the abnormal and 
normal ROI. 
The four contrast metrics were computed from dysplastic and cancerous lesion 
sites. The contrast metrics for the autofluorescence, narrowband reflectance, and cross 
polarized reflectance image types are reported relative to the same contrast metric for the 
white-light image obtained from that site. For each image type, the percentage of lesions 
with a higher optical contrast than white-light was computed. One-way ANOVA was 
used to compare the mean contrast metrics for each image type to that for white light. 
In order to explore the relationship between optical contrast and pathologic grade, 
a scatter plot of the contrast metrics versus pathologic diagnosis was made for image 
types with the greatest image contrast. Unbalanced one-way ANOVA was used to 
compare the statistical difference in mean optical contrast between diagnostic categories. 
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5.2.4 Computer Aided Diagnosis 
Figure 13 provides an overview of the algorithm development and 
evaluation procedure used in this study. After image acquisition, registration, and ROI 
selection, image features were extracted from each ROI. In cases where image 
acquisition was repeated from the same tissue location, feature values extracted from the 
repeat images were averaged and considered as a single measurement site. Image features 
were designed to quantify statistical measures, texture, and frequency content 
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In order to determine the image types and modalities or combination of modalities 
most capable of discriminating neoplastic lesions, algorithms were developed and 
evaluated using features extracted from five groups, including: (1) Features obtained 
from white-light reflectance images; (2) Features obtained from narrowband reflectance 
images at 430 nm and 530 nm illumination; (3) Features obtained from cross polarized 
reflectance images; (4) Features obtained from autofluorescence images at 365 nm, 380 
nm, 405 nm, and 450 nm excitation; and (5) Features obtained from all of the modalities 
and image types. 
Two different supervised classifiers (a linear classifier and a decision tree 
classifier) were then used to construct diagnostic algorithms based on features from 
images in the training set. For each classifier, features were chosen using a feature 
selection algorithm. The results from the two methods were compared to the gold 
standard of histopathology and the algorithm with the highest performance was then used 
to classify data from the validation set. 
Algorithms were designed first to classify the ROIs into one of two diagnostic 
categories: non-neoplastic and neoplastic. The neoplastic class included lesions 
diagnosed histopathologically as mild, moderate, or severe dysplasia, carcinoma in situ, 
or invasive carcinoma. The non-neoplastic class included clinically normal sites in 
patients and normal volunteers. We then attempted the more difficult problem of 
designing classifiers to assign ROIs into one of three diagnostic categories: non-
neoplastic, dysplasia, and cancer. 
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5.2.5 Feature Extraction: 
For each ROI site, 98 image features were computed for each image type, 
as described in detail below. 
The Michaelson and Weber contrast were computed from the grayscale images 
and from each color channel of the RGB images, resulting in 8 features for each image 
type. 
18 first-order statistical features were calculated using the grayscale pixel values 
from the ROIs, including the mean, standard deviation, entropy, variance, skewness, and 
kurtosis. These features were calculated for each ROI and as normalized by features from 
the normalization ROIs selected from clinically normal areas. Normalization was 
performed in two ways; the first was calculated as the difference between the ROIs 
(difference-normalization), and the second was the ratio of the ROIs (ratio-
normalization). 
18 features were obtained using the color channels of measurements. The mean 
values of the red, green, and blue channels of each ROI were used as features. The ratio 
of the mean red-to-green, red-to-blue, and green-to-blue pixel values were also utilized. 
Both normalized and non-normalized feature values were calculated. 
Features representing texture in the images were obtained by using grayscale-
level co-occurrence matrices (GLCM). GLCMs are useful for quantifying how pixel 
intensities vary spatially. A pixel separation, d, and angle, 0, are specified for a particular 
GLCM. The size of the GLCM is determined by the number of discrete intensity values 
contained in the grayscale image. Each entry (i,j) in the GLCM is a count of the number 
of times a pixel of intensity i occurred at a distance d and angle 9 away from a pixel with 
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intensity/. Statistical measures including contrast, correlation, energy, and homogeneity 
were computed from the GLCMs. More detail is provided in Argenti et al. [114]. 
24 features were created based on these statistical measures from GLCMs where d 
varied from 1 to 6. The features were averaged at angles 9 = 0° , 45°, 90°, and 135° to 
account for the fact that these multispectral images do not have a specific spatial 
orientation. 
A 2-D DFT was performed on a rectangular region whose center corresponded to 
the approximate center location of the selected ROIs. This 2-D DFT was converted into a 
1-D plot of frequency content by integrating the pixel intensities at discrete radii from the 
origin. The 1-D plot was then partitioned into 10 frequency ranges and the frequency 
content was integrated inside each range. The contribution of each partition was 
calculated by dividing by the total integrated 1-D plot so that the sum for all 10 partitions 
added to unity. 
30 features were computed using the relative frequency content for the partitions. 
Normalized and non-normalized feature values were included. Variations of this method 
have been used by Gossage et al. and Srivastava et al. [57,108] 
5.2.6 Linear Classifier 
We implemented a linear classifier (LC) based on Bayesian parameter estimation. 
This method assumes multivariate normal densities and equal covariance for each class. 
The LC is trained on a data set which is used to estimate the mean Uj for each class and a 
pooled covariance matrix £ for all classes. A priori probabilities are determined from the 
relative proportion of each class in the training set; posterior probabilities are output for 
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each measurement and used by a linear discriminant function to separate the 
measurements into classes. 
5.2.7 Decision Tree Classifier 
We utilized a decision tree classification method based on the widely used 
Classification and Regression Tree (CART) induction technique. This method has the 
attractive attribute of classifying data without the need to make assumptions about the 
underlying statistical distributions of the observations [62]. We used the Gini impurity to 
determine splits [59,62]. To help avoid overtraining the decision tree in the training set it 
was pruned to find the smallest tree at which adding further nodes does not statistically 
decrease the cost of the tree. The cost of the tree is defined in the zero-one sense, where 
the cost of misclassifying an observation is 1 and the cost of correctly classifying an 
observation is 0. 
5.2.8 Feature Dimension and Selection 
A forward sequential search (FSS) algorithm based on the wrapper model was 
used on the training set to determine the optimal feature dimension: the minimum number 
of features needed to maximize a chosen classifier performance criterion without 
overtraining [59,63]. Starting with one feature, classification of the training set was 
performed with 5-fold cross-validation using the FSS algorithm to find the single feature 
which maximized the criterion value. The area under the curve (AUC) of the receiver-
operating characteristic (ROC) was used as the criteria for the FSS algorithm for the LC. 
For the decision tree, the sum of the sensitivity and specificity was used. This was 
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repeated with additional features until classifier performance did not increase. This entire 
procedure was repeated 25 times to provide statistically significant results. One-way 
ANOVA with multiple comparison tests were used to determine the optimal feature 
dimension. The final features sets for each classifier were determined by the most 
commonly chosen features by the FSS algorithm in the 25-iterations. This entire 
procedure was repeated for each of the five imaging modality-based feature subsets. 
5.2.9 Classification Performance 
The classifier performance for the training set was determined using 5-fold cross-
validation. For 2-class classification, we utilized sensitivity and specificity as the figures-
of-merit (FOM) to evaluate and compare the performance of the classifiers on the 
training set for each of the feature subsets. For 3-class classification we utilized the FOM 
of total correct classification rates and correct classification rates for each class. Based 
on these results, the best performing classifier for the 2-class and 3-class problem was 
retrained on the entire training set and then applied without change to evaluate the 
validation set. 
5.3 Results 
5.3.1 Data Collection 
In total, images were acquired from 72 subjects, including 61 patients with 
pathologically confirmed oral lesions and 11 normal volunteers. From these images, we 
defined 350 ROI measurements sites in the study. There were 93 non-neoplastic ROIs, 
and 82 neoplastic ROIs each with a corresponding normalization ROI. The neoplastic 
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ROIs consisted of 22 ROIs with mild dysplasia, 13 ROIs with moderate dysplasia, 16 
ROIs with severe dysplasia or carcinoma in situ, and 31 ROIs with invasive cancer. 
The ROIs were divided into training and validation sets. Not including 
normalization ROIs, there were 102 ROIs from 46 patients in the training set and 73 
ROIs from 26 patients in the validation set. The training set was collected on dates 
before the validation set. No data was repeated in both sets. 
5.3.2 Optical Contrast 
Figure 12 illustrates selection of ROIs from multispectral images from the 
palate of a normal volunteer and the palate of a patient with severe dysplasia. White-
light, 530 nm narrowband reflectance, 405 nm autofluorescence, and white-light cross 
polarized reflectance images are shown. ROI locations are indicated by circles in the 
white-light images. The image in IE shows red fluorescence on the dorsal tongue of the 
normal volunteer. This was a common observation on the dorsal tongue of both normal 
volunteers and patients. A chart of example features and contrast metric values, which 
will be described below, are shown. In this example, all contrast and feature values are 
increased in the patient with severe dysplasia. 
The results obtained using different definitions of image were similar (data not 
shown); thus, we report only results from a single contrast metric. Figure 14A shows a 
box plot of the Michaelson contrast metric by image type; contrast for each image type is 
reported relative to the contrast achieved using white-light illumination. For each image 
type, Fig. 3A also indicates the percentage of lesions where contrast was greater in that 
image type than in white light. On average, the contrast for each of the image types is 
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greater than that available in white light mode. Autofluorescence imaging at 405 nm 
showed the greatest average increase in contrast and the greatest percentage of abnormal 
lesions with increased contrast relative to white-light imaging. The mean contrast value 
for autofluorescence at 365 nm, 380 nm, 405 nm, and 450 nm excitation was found to be 
statistically different than that of white light imaging, using one-way balanced ANOVA 
with a 95% confidence interval. 
A subset of 26 patients was imaged with narrowband illumination at 575 nm. 
From this subset there were 41 lesion sites. The 575 nm narrowband imaging provided 
an increase in Michaelson contrast over white light in 80% of these lesions. The median 
increase was 1.15, which was similar to the other narrowband illuminations but was 
significantly less than that achieved from the autofluorescence modality. 
Autofluorescence images at 405 nm excitation show the greatest increase in 
optical contrast compared to white light images when discriminating non-neoplastic from 
neoplastic tissue. In order to explore whether optical contrast in this image type 
increased with increasing grade of dysplasia or cancer, we plotted the contrast of each 
lesion by diagnostic category (Fig. 3b). The means for the diagnostic categories are 
shown in the shaded boxes. The mean contrast of normal tissue is a significantly lower 
than that of dysplasia and cancer, when calculated using one-way unbalanced ANOVA 
with 95% confidence interval. However, the mean contrast values for each of the 
dysplastic categories and cancer were not statistically different from each other. 
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Figure 14. A shows a boxplot of the increase in Michaelson contrast 
compared to white light when using narrowband reflectance 
imaging, autofluorescence imaging, and cross polarized reflectance 
imaging. The imaging modality is indicated on the x-axis. For each 
modality, the percentage of lesions where the contrast was increased 
over white light is indicated near the top of the plots. The three 
horizontal lines on each of the boxes represent the lower quartile, 
median, and upper quartile of the data from bottom to top. The 
whiskers extending from the box indicate the rest of the data except 
for outliers, which are indicated with the "." symbol. 2B shows the 
Michaelson grayscale contrast computed from the 405 nm 
autofluorescence images. The contrast values are displayed by 
graded diagnostic category. The shaded squares in each diagnostic 
cluster indicate the location of the mean contrast value. There is a 
statistically significant difference in contrast between normal and 
the other diagnostic categories, but not between the grades of 
dysplasia or the carcinoma. 
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5.3.3 Computer Aided Diagnosis 
5.3.3.1 2-class classification 
Table 6 lists the number of features selected and summarizes the classifier 
performance for both the LC and decision tree methods using 5-fold cross validation for 
the training set. For both classifiers, the best performance was obtained using the 
autofluorescence feature subset. Furthermore, the only feature chosen by the FSS in the 
combined feature subset was a single feature from the autofluorescence modality subset. 
Features extracted from white-light images provided the second best performance 
after autofluorescence for both of the classifiers on the training set; classification required 
five features for the LC and 3 features for the decision tree. Narrowband reflectance 
provided the third best classification with 4 features. Cross-polarized provided the worst 
classification with 6 features for the LC and 3 features for the decision tree. 
Figure 15 shows ROC curves produced from the LC on the training set using 5-
fold cross-validation and the same features used above. The autofluorescence feature 
subset produced the highest AUC followed by white-light, narrowband, and cross 
polarized features. 
The autofluorescence feature chosen for the LC was the ratio of red-to-green 
intensity (difference-normalized). For the training set, this single feature provided an 
AUC of .981 and a sensitivity of 93.9% and a specificity of 98.1%. The feature chosen 
from the decision tree was very similar, the ratio of ratio of red-to-green intensity (ratio-
normalized). For the training set, this single feature provided a sensitivity of 95.9% and a 
specificity of 92.5%. 
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The LC was used on the validation set because it provided a slightly higher sum 
of sensitivity and specificity than the decision tree. Using these same features, the 
algorithm was retrained on the entire training set and applied to the validation set yielding 
an AUC of .949, a sensitivity of 100%, a specificity of 85.0%, a PPV of 84.6%, and a 
NPVofl00%. 
Table 6. Two-class classification results of the training data for the 
linear classifier (LC) and the decision tree classifiers. The area 
under the curve (AUC) of the receiver operating characteristic curve, 
sensitivity, and specificity are shown for the LC. Sensitivity and 
specificity are indicated at the q-point on the ROC curve. The 
sensitivity and specificity are shown for the decision tree classifier. 
The number of features chosen is indicated for each feature subset. 
Feature Subset 
White Light 
Narrowband 
Cross Polarized 
Autofluorescence 
Numof 
Feats. 
5 
4 
6 
1 
LDA 
AUC 
.931 
.847 
.898 
.981 
Se (%) 
87.8 
81.6 
83.7 
93.9 
Sp(%) 
88.7 
75.7 
75.5 
98.1 
Decision Tree 
Numof 
Feats. 
3 
4 
3 
1 
Se (%) 
87.8 
83.7 
85.7 
95.9 
Sp(%) 
84.9 
83.0 
77.4 
92.5 
Combined 1 .981 93.9 98.1 1 95.9 92.5 
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Figure 15. ROC curves from the 2-class LC for different feature 
subsets on the training set. When considering the AUC of the ROC 
plots, the autofluorescence features performed the best, followed by 
white light, narrowband, and cross polarized. Note that these ROC 
plots are from a single iteration of LC classification on the training 
set and therefore the parameters may not match exactly to table 6. 
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5.3.3.2 3-class classification 
Table 7 lists the number of features chosen for the three-class LC and the decision 
tree classifier using 5-fold cross-validation. Algorithm performance is also summarized 
in Table 7, as the percent of sites correctly classified for all sites and for each of the 
three diagnostic categories. 
The best performance from both classifiers was from the autofluorescence feature 
subset using the decision tree; in the training set this classifier correctly classified 94.3% 
of the non-neoplastic ROIs, 75.9% of the dysplasia ROIs, and 80% of the cancer ROIs. 
The first feature chosen was the ratio of red-to-green intensity (ratio normalized) from the 
405 nm autofluorescence image; this was the same feature chosen for the 2-class problem 
by the decision tree. The second feature was the GLCM homogeneity with d=6 
calculated from the 380 nm autofluorescence image. For both classifiers in the training 
set, autofluorescence features and white-light features were chosen in the combined 
feature subset, but this combination did not improve performance, based on overall 
correct classification rate, over the autofluorescence only feature subset. 
The decision tree classifier was then retrained on the entire training set and 
applied to the validation set. Results are summarized in Table 8. In the training set, this 
method misclassifies 5.7% (3 of 53) non-neoplastic ROIs as dysplasia, 17.2% (5 of 29) 
dysplasia ROIs as cancer, 3.4% (1 of 29) dysplasia ROIs as non-neoplastic, and 20% (4 
of 20) cancer ROIs as dysplasia. No cancerous ROIs were misclassified as non-
neoplastic and no non-neoplastic ROIs were misclassified as cancer. 
In the validation set, 20% (8 of 40) non-neoplastic ROIs were misclassified as 
dysplasia and 81.8% (9 of 11) cancerous ROIs were misclassified at dysplasia. 100% (22 
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of 22) dysplastic ROIs were correctly classified. No cancerous ROIs were misclassified 
as non-neoplastic and no non-neoplastic ROIs were misclassified as cancer. 
Table 7. Three-class classification results of training set for LC and 
decision tree classifier. All results are computed using 5-fold cross-
validation. 
Feature Subset 
Linear Classifier Decision Tree 
Nutn of Tolal Normal Dys. Cancer 
Feats. Correct Correct Correct Correct 
(%> (%) («„) m 
Num of Total Normal Dys. Cancer 
Feats. Correct Correct Correct Correct 
{%) (%) (»i.) (%) 
White Light 
Narrowband 
Cross Polarized 
\utofluorescence 
4 
5 
5 
4 
81.4 
65.6 
61.8 
84.1 
92.5 
88.7 
90.6 
98.1 
65.5 
37.9 
34 5 
79.3 
75.0 
45.0 
25.0 
55.0 
2 
2 
3 
2 
72.6 81.1 75.9 45.0 
72.6 79.3 69.0 60.0 
69.6 84.9 58.6 45.0 
86.3 94.3 75.9 80.0 
Combined 77.5 943 69.0 45.0 83.3 96.2 79.3 550 
Table 8. Confusion matrices of 3-class classification results from the 
decision tree using two autofluorescence features. Numeric values 
indicate the number of classified measurement sites. Results from 
both the training set and validation set are shown without cross-
validation. 
Decision Tree 
Results 
Training Set Validation Set 
Truth Truth 
Normal Dysplasia Cancer Normal Dysplasia Cancer 
•o 
3 
! £ 
Normal 
Dysplasia 
Cancer 
50 
3 
0 
1 
23 
5 
0 
4 
16 
32 
8 
0 
0 
22 
0 
0 
9 
2 
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5.4 Discussion 
In this study multispectral widefield imaging data from 72 study subjects were 
analyzed to determine the imaging modalities, illumination/detection conditions, and 
image features which provide the greatest optical image contrast between oral lesions and 
surrounding non-neoplastic tissue, and to determine if objective classification algorithms 
could be used to diagnostically classify oral lesions. 
78% of the lesions imaged showed greater contrast when imaged in 
autofluorescence mode at 405 nm illumination that in white light mode. These lesions 
included all grades of dysplasia and carcinoma. When the contrast was analyzed by 
diagnostic category, contrast was significantly greater for all pathologies compared to 
non-neoplastic areas but contrast was not significantly different for images of lesions 
with different pathologic grades. This suggests the contrast observed using 
autofluorescence may be due to changes which occur early in malignant transformation. 
Narrowband images and cross-polarized images showed an increase in contrast over 
white light in the majority of images but not to the extent of the autofluorescence images. 
2-class classification performance using both the LC and decision trees was 
excellent in the training set, providing sensitivities and specificities exceeding 90% for 
both classifiers. It is clear from the analysis that color-based features extracted from 
autofluorescence images at 405 nm were highly dominant, demonstrated by the fact that a 
single feature of this type was chosen using both classifiers, even with access to the entire 
feature set. The combination of features from multiple subsets did not improve 2-class 
classifier performance above that from the autofluorescence feature subset alone. The 
LC was applied to data from the validation set, yielding 100% sensitivity and 85% 
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specificity, helping to confirm the diagnostic capability of the 405 nm autofluorescence 
image type. 
For the 3-class problem, the decision tree modestly outperformed the LC 
in the training set. Two features based on autofluorescence were selected after pruning in 
the two-step decision tree. The first feature, the ratio of red-to-green intensity (ratio-
normalized) at 405 nm excitation, was Used to classify non-neoplastic sites from 
dysplastic and carcinoma sites, just as in the 2-class problem. The second feature was 
then used to separate the dysplastic lesions from the carcinoma lesions. This second 
feature was produced by texture analysis and was from the 380 run excitation 
autofluorescence image. In the validation set, 0% (0 of 22) of the dysplastic lesions were 
misclassified but 81.8% (9 of 11) of the carcinoma lesions were misclassified as 
dysplasia. This suggests that the second feature may not generalize well to new data to 
discriminate dysplasia from cancer. 
These data suggest that it may not be feasible for widefield multispectral optical imaging 
to discriminate different abnormal diagnostic categories using the specific modalities and 
wavelengths tested here. Based on results from Pavlova et al., it may be necessary to 
selectively probe the epithelial in order to obtain a more specific diagnosis using optical 
techniques [6,115]. Results from both the contrast analysis and classification portions 
of this study indicate that dysplastic and cancerous oral lesions can be discriminated from 
normal tissue using the autofluorescence imaging modality at 405 nm excitation. It was 
shown that the reflectance white light, narrowband, and cross-polarized images included 
in this analysis did not improve the diagnostic ability available from the autofluorescence 
images. This is somewhat surprising given that the signal from autofluorescence and 
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reflectance modalities are likely dominated by two different biological phenomenon 
during malignant progression: the breakdown of the supporting tissue structure in the 
stroma [6], and the increase in vascularity in and around lesions [73] respectively. 
Several groups have previously demonstrated that increased contrast of lesions 
observed using autofluorescence imaging with blue excitation light (400 nm - 460 nm) is 
an effective diagnostic means for high-grade oral lesions [14,51,55]. Poh et al. reported 
that an observed visual decrease in autofluorescence signal often extended beyond 
clinical tumor margins up to 25mm [88]. Lane et al. showed a sensitivity of 98% and a 
specificity of 100% for the discrimination of severe dysplasia and carcinoma from direct 
autofluorescence visualization [21]. This work has achieved comparable diagnostic 
performance using an objective discrimination technique while including low-grade as 
well as high-grade lesions. 
Multispectral widefield optical imaging has the potential to improve upon current 
oral cancer screening and delineation methods. The use of 405 nm excitation 
autofluorescence imaging of the oral mucosa can increase the optical image contrast of 
lesions above that observed using white light and can provide objective classification of 
neoplastic lesions with high accuracy. 
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CHAPTER 6: WIDEFIELD MULTISPECTRAL IMAGING AND HIGH 
RESOLUTION MICROENDOSCOPE IMAGING FOR DETECTION OF 
ORAL NEOPLASIA4 
6.1 Introduction 
Squamous carcinoma of the head and neck is associated with poor five-year 
survival, usually a consequence of late-stage disease at diagnosis [1]. Treatment of oral 
cancer is associated with severe morbidity; surgical removal of oral tissue often results in 
disfigurement and impairs speech and the ability to swallow. Diagnosis of head and neck 
cancers at an earlier stage can improve reduce morbidity and improve efficacy of therapy, 
leading to improved patient survival and quality of life. 
The current standard-of-care to screen for oral cancer is white light inspection of 
the oral cavity by an expert clinician, followed by biopsy and histologic analysis of 
suspicious lesions. Subjective visual examination requires adequately trained personnel, 
as well as the availability of histopathology labs to analyze biopsy specimens of 
suspicious lesions. Even in developed nations, lesions are commonly not discovered until 
a late stage because of the relative lack of screening. 
Optical methods offer a means to improve screening for oral neoplasia at the point 
of care without the need for extensive infrastructure. Autofluorescence visualization is a 
promising tool to detect early neoplastic changes in the oral epithelium. The Velscope is 
4
 The content for this chapter is being prepared for publication. Both I and Timothy Muldoon have 
contributed equally to the work presented in this chapter. The following authors have also contributed: 
Kelsey Rosbach, Vanda Stepanek, Michelle D. Williams, Ann M. Gillenwater, Rebecca Richards-Kortum. 
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a commercial system that uses blue light to excite autofluorescence in the oral mucosa; a 
clinician can then visually inspect the mucosa and identify suspicious areas based on loss 
of autofluorescence [21,80]. It has been demonstrated that precancer and cancer are 
associated with loss of stromal collagen fluorescence [6]. 
Computer-aided tools and quantitative classification algorithms can be used to 
further improve the screening process and provide an objective diagnosis. Digital 
imaging of the autofluorescence signal from the oral mucosa allows quantifiable image 
parameters to be calculated; the red-to-green pixel intensity ratio has been of particular 
importance in distinguishing between neoplastic and non-neoplastic sites. A recent study 
by our group using this technique achieved a sensitivity of 100% and specificity of 91.4% 
in an independent validation data set [111]. 
A potential limitation of widefield imaging and analysis of the bulk tissue 
autofluorescence signal is that this modality does not directly sample some of important 
pathologic features, such as changes in cellular and nuclear morphology. High-resolution 
imaging may be used to complement the diagnostic capability of widefield imaging. 
High-resolution imaging can be used to directly observe changes in epithelial cell 
morphology and epithelial architecture over small fields-of-view. These changes include 
increased nuclear-to-cytoplasmic ratios, pleomorphism, and alterations in the gradation of 
cellular differentiation throughout the epithelium. A variety of high resolution optical 
imaging modalities are available to sample these morphologic and architectural changes, 
including confocal micrscopy, optical coherence microscopy and high resolution 
microendoscopy [116-118]. 
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Multimodal imaging approaches which combine images from wide field and high-
resolution modalities have the potential to improve early detection of neoplastic changes. 
Wide field imaging allows for rapid inspection of nearly the entire oral cavity, while 
high-resolution imaging can be used to interrogate suspicious regions with higher spatial 
resolution. 
The goal of this study was to explore the complementary diagnostic ability of 
widefield autofluorescence imaging ad high resolution microendoscopy for early 
detection of oral neoplasia. Widefield autofluorescence images were obtained from 
resected oral tumors; high resolution images were then obtained following topical 
application of a fluorescent contrast agent to visualize changes in nuclear morphbmetric 
and density. The ability to classify oral tissue as normal or neoplastic was explored 
using data from widefield imaging along, high resolution imaging alone and the 
combination of the two modalities. Multimodal approaches yielded the greatest 
sensitivity and specificity relative to the gold standard of histopathology, supporting the 
complementary role of these two imaging approaches. 
6.2 Methods 
6.2.1 Data Acquisition and Instrumentation 
Data was collected under a clinical protocol approved by the Institutional Review 
Boards at the University of Texas MD Anderson Cancer Center and Rice University. All 
participating subjects gave written informed consent. Patients were eligible if they were 
18 years old or older and were scheduled for surgical resection of a known precancerous 
or cancerous lesion in the oral cavity. 
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Following resection, tissue was imaged in the laboratory using first a widefield 
multispectral digital microscope (MDM) and then a high resolution microendoscope 
(HRME) system. The MDM is described in detail elsewhere [96]. Briefly, the MDM 
system is a modified clinical microscope which collects digital images with an 
approximate 5 cm by 7 cm field of view (FOV). The system is capable of collecting data 
in several different imaging modalities but for this study only white light reflectance and 
autofluorescence images at 405 nm excitation were utilized. The entire mucosal surface 
of the resected tissue was imaged using the MDM. 
The HRME system is described in detail elsewhere [119]. Briefly, the system can 
image cellular detail of the upper epithelium by placing a fiber optic image guide guide 
into direct contact with the tissue. Contrast is achieved by applying a topical solution of 
proflavine (0.01% in water) with a cotton swab immediately before imaging. Proflavine 
is a fluorescent agent that binds to DNA, yielding bright nuclei surrounded by dark 
cytoplasm. The HRME system uses an LED with a center wavelength of 455 nm as an 
excitation source; this is directed through an objective lens and coupled to the fiber optic 
image guide, which delivers it to the tissue surface. Fluorescence emission light travels 
back though the image guide, is magnified by the objective lens, arid is imaged to a CCD 
camera, where it is digitally stored and sent to a PC. The HRME system has a circular 
field of view with a diameter of 750 microns, and collects image data at 4 frames per 
second. 
Both clinically normal and suspicious areas were measured with both the MDM 
system and the HRME system. Several suspected non-neoplastic and neoplastic sites 
were imaged on each resected specimen. HRME images were qualitatively assessed by 
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the authors (TJM and DMR) for the presence of nuclear detail. Only HRME images 
which revealed nuclear detail were included in this study. For each interrogated tissue 
site, one or more HRME images were collected inside a small, approximately 2 
millimeter diameter area. 
Histopathology diagnosis was obtained from the sites imaged with the MDM and 
HRME. The locations of regions imaged with the HRME were recorded using digital 
photography, and these locations were tracked throughout histopathology processing. 
The resected tissue was sectioned and stained according to standard histopathology 
practice and diagnosis was obtained from prepared slides by an expert Head and Neck 
pathologist (M.D.W.). 
6.2.2 Computer Aided Diagnostics 
Image data obtained with both the MDM and HRME were used to develop 
objective classifiers to identify neoplastic tissue. Images from each device were first 
processed and used to train a linear discriminant classifier based on a single imaging 
modality. MDM and HRME results were then combined using multiple hybrid 
consensus techniques to train multimodal classifiers. Tissue sites imaged with both the 
MDM and HRME and with a corresponding pathologic diagnosis were included in this 
analysis. 
For analysis of MDM data, circular regions of interest (ROIs) with a 20 pixel 
diameter, which correspond to an approximate 1mm diameter circular region of tissue, 
were selected from MDM images at sites imaged by the HRME. In addition, a 
normalization ROI was identified in each specimen from a pathologically normal area, 
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distant from any lesion. Features obtained from the pixel values inside these regions 
were then extracted. Previous in vivo studies have shown that the mean ratio of red to 
green autofluorescence at 405 nm excitation, normalized to a known non-neoplastic 
region, provides a high degree of discrimination between non-neoplastic and neoplastic 
tissue [96,120]. This feature was extracted from the ROIs of MDM images collected in 
this study; these values were normalized by the mean red to green autofluorescence ratio 
from the normalization ROIs. 
This feature was used as input to a 2-class linear classifier based on Bayesian 
parameter estimation in order to obtain a predicted diagnosis of either non-neoplastic or 
neoplastic. The neoplastic class includes ROIs with diagnoses of mild, moderate, and 
severe dysplasia as well as carcinoma in situ and invasive carcinoma. The non-neoplastic 
class included epithelial tissue which was histopathologically normal with or without 
hyperplasia, hyperkeratosis, or inflammation. Leave-one- patient-out cross-validation 
was used avoid overtraining the algorithm [63]. A posterior probability was obtained for 
each site which is the predicted probability that the site is in the neoplastic class. A 
receiver-operating-characteristic (ROC) curve was generated by changing the threshold 
of the posterior probability value used to determine if a measurement was in the first or 
second class, and then plotting 1-specificity versus sensitivity at each threshold value or 
operating point. The area under the curve (AUC) of the ROC plot was used as a figure-
of-merit (FOM) to determine classification performance. Sensitivity, specificity, positive 
predictive value, and negative predictive value were also determined at the operating 
point which maximized the sum of sensitivity and specificity and reported. 
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A variety of features were extracted from the HRME images at each site and used 
as input to a linear classifier. Regions of interest were manually selected from each 
HRME image, corresponding to regions subjectively showing the most nuclear detail. In 
addition, this ROI selection was done to eliminate the boundaries of the images, which 
did not contain any information. Features were extracted from these rectangular ROIs. In 
the cases where there was more than one HRME image collected from a site, the mean of 
these feature values was used for classification. First order statistical features such as the 
mean, standard deviation, and entropy of pixel values were extracted from the ROIs. 
Textural features obtained from gray-level co-occurrence matrices with pixel offsets from 
1 to 10 pixels were also obtained. Spatial frequency content features were extracted by 
performing a 2-D Fourier transform on the image data inside the ROIs. Further detail 
about these features is provided in [120]. 
In order to select the most diagnostically valuable features from the HRME data, a 
forward sequential feature selection algorithm was implemented [63]. This algorithm 
tested each feature separately and then in combination using the linear classifier to 
determine the two features which classified the data most accurately based on maximal 
area under the ROC curve. Two features were chosen because adding additional feature 
did not statistically improve classification performance. The HRME data were classified 
using the linear classifier with the two selected features using leave-one-out cross-
validation. Again, a posterior probability was obtained for each site An ROC plot, AUC, 
sensitivity, specificity, positive predictive value, and negative predictive value were 
obtained. 
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6.2.3 Combinatorial Methods 
Two separate strategies were implemented to combine data from both imaging 
modalities to yield a single diagnosis. The first approach used was to develop a classifier 
using input from both imaging modalities to obtain a single diagnosis. We refer to this 
technique as the Nondirected Combinatorial Technique. The second strategy, referred to 
as the Directed Combinatorial Technique, used data from the MDM to first identify 
potentially neoplastic sites. At these sites, data from both the MDM and HRME 
modalities were used to classify the site as neoplastic or non-neoplastic. The Directed 
Combinatorial Technique was implemented by first using data from the MDM to train 
and test a linear classifier using input from all of the measurement sites. The operating 
point for this classifier was selected such that a sensitivity of 90% was achieved. Sites 
classified as non-neoplastic by this algorithm were not analyzed further. Sites classified 
as potentially neoplastic by this algorithm were analyzed further. A second algorithm 
was developed using both MDM and HRME data from these sites. 
For both the Directed and Nondirected Combinatrorial Techniques, we explored 
eleven different methods to combine the results from two devices. Eight of these 
methods rely on combining the posterior probabilities obtained from each device for each 
site to produce a new metric which can be used to discriminate the classes. Many of 
these methods are described by Bendiktsson et al. [121]. The other three methods 
explored involve utilizing one or more classifiers in a different way, as described below. 
The posterior probabilities (pp) per site were combined from the two devices in 
the following eight ways: 
1. The maximum of the two pp's was used, 
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2. The minimum of the two pp's was used, 
3. The mean of the two pp's was used, 
4. The weighted sum of the two pp's was used where the weights were determined 
heuristically by the relative performance of each device. We have used the AUC 
obtained from each device as the FOM to determine the weights. This method is 
called Linear Opinion Pool (LOP). 
5. The weighted sum of the two pp's (LOP) was used where the weights were 
determined by a search of different weights. The weights of each device were 
between 0 and 1 and the weight from the second device W2, was equal to 1-w;, 
where wi is the weight for the first device. Weights were tested in .01 increments. 
6. The product of the two pp's was used. This method is called Logarithmic Opinion 
Pool(LOGP). 
7. The weighted product of the two pp's (LOGP) was used where the weights were 
determined by a search. The weights were applied as exponents for the pp's. 
8. The weighted sum of the two pp's (LOP) was used where weights were 
determined both per device and per class. This method is described in 
reference[121]. 
In addition to these methods, three other methods were used to synthesize the 
data. The pp from the MDM was used as the prior probability for the HRME linear 
classifier; extracted features from both devices were used in a single linear classifier; and 
the pp from the MDM was used as an additional feature for the HRME linear classifier. 
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6.3 Results 
In total, resected specimens were obtained from 14 patients. Six of the resected 
specimens primarily involved the tongue, three primarily involved the floor of mouth, 
two primarily involved the buccal mucosa, one primarily involved the retromolar trigone, 
one involved the tongue and floor of mouth and one involved the gingiva and floor of 
mouth. From these specimens, 69 unique measurement sites were matched to a 
corresponding pathology diagnosis. These sites included 26 sites with a diagnosis of non-
neoplastic, 3 sites with mild dysplasia, 4 sites with moderate dysplasia, 13 sites with 
severe dysplasia or carcinoma in situ, and 23 sites with invasive squamous cell 
carcinoma. When divided into two classes: the non-neoplastic class contains 26 sites and 
the neoplastic class contains 43 sites. 
A ROI from the MDM autofluorescence images was selected at the each of the 69 
sites. A normalization ROI was chosen for each patient and corresponded to a 
histopathologically normal area. 126 HRME ROIs were obtained from the 69 sites; when 
multiple ROIs were available, the features were averaged together. 
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Figure 16. A. MDM Autofluorescence image at 405 nm excitation 
from resected tissue from the floor of mouth. MDM ROIs from a 
squamous cell carcinoma (SCC) site and a non-neopalstic site are 
indicated. B. HRME image collected from the SCC site. C. HRME 
image collected from the non-neoplastic site. 
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Table 9. This combinatorial methods and the AUC achieved. Both 
devices were used to measure all measurement sites. The percent 
increase in AUC values over each device alone is shown. Method 5 
produced the highest AUC. 
Combination Method 
1. Maximum posterior probability. 
2. Minimum posterior probability. 
3. Mean posterior probability. 
4. LOP, Weighted sum of posterior probabilities, 
weights determined from individual AUC for devices. 
5. LOP, Weighted sum of posterior probabilities. 
weights determined from search. 
« W = . 8 9 , W W = . H 
6. LOGP, Product of posterior probabilities. 
7. LOGP, Weighted Product of posterior probabilities, 
weights determined from search. 
WMD^.H, W//RAffi=13 
8. Weights determined for device and class. 
9. MDM posterior probability used as HRME prior probability. 
10. MDM posterior probability used as feature in HRME classifier. 
11. One classifier using features from both devices. 
AUC 
.794 
.824 
.810 
.772 
.875 
.811 
.819 
.789 
.817 
.784 
.790 
% increase 
over MDM 
.68 
4.4 
2.7 
-2.2 
10.9 
2.8 
3.9 
-.06 
3.5 
-.68 
.11 
% increase 
over HRME 
5.6 
9.6 
7.8 
2.6 
16.4 
7.9 
9.0 
4.9 
8.6 
4.2 
5.1 
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Figure 17. Results from the Nondirected Combinatorial Technique. 
Each device was used to measure all of the measurement sites. A. 
Scatterplot of normalized red to green ratio per measurement site 
calculated from MDM images. The indicated discrimination line 
yields a sensitivity of 79.1% and a specificity of 69.2%. B. ROC 
curve produced by the linear classifier using this feature. The 
indicated operating point corresponds to the discrimination line in 
A. C. Scatterplot of the two selected features from the HRME. The 
indicated discrimination line yields a sensitivity of 69.8% and a 
specificity of 80.8%. D ROC curve produced by the linear classifier 
using these features. The indicated operating point corresponds to 
the discrimination line in C. E. The ROC curves in B. and D. with 
the ROC curve produced by combination method 5 in table 9: the 
weighted linear opinion pool of posteriors probabilities from each 
device. 
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Figure 16A shows a representative MDM autofluorescence image at 405 nm 
excitation collected from resected tissue from the floor of mouth. MDM ROIs are 
indicated from a site with squamous cell carcinoma (red circle) and a site which is non-
neoplastic (blue circle). Note the relative decrease in autofluorescence at the carcinoma 
site. Figure 16B shows an HRME image collected at the carcinoma site. Figure 16C 
shows an HRME image for the non-neoplastic site. Note the nuclear crowding and 
disorganized architecture in 16B compared to 16C. 
Figure 17 shows results from the Nondirected Combinatorial Technique where 
data from both devices was used from all measurement sites. Figure 17A is a scatterplot 
of normalized red to green ratio per measurement site calculated from MDM images. 
The indicated discrimination line yields a sensitivity of 79.1% and a specificity of 69.2%. 
Figure 17B is the ROC curve produced by the linear classifier using this feature alone. 
The indicated operating point corresponds to the discrimination line in Figure 17 A. and is 
located at the Qpoint, the point on the ROC curve which is the minimum distance from 
the upper left hand corner of the plot. Figure 17C is the scatter plot of the two selected 
feature values from the HRME. The two features chosen by the sequential feature 
selection algorithm were pixel grayscale variance (a first-order feature) and the pixel pair 
correlation value calculated from the gray level co-occurrence matrix at an offset of 1. 
The indicated discrimination line yields a sensitivity of 69.8% and a specificity of 80.8%. 
Figure 17D is the ROC curve produced by the linear classifier using these features. The 
indicated operating point corresponds to the discrimination line in 17C and is also at the 
Qpoint. 
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Table 9 indicates the AUC achieved using each of the 11 methods to combine 
data from the two modalities. Table 9 also summarizes the change in AUC for the 
combined modalities relative to the AUC achieved using each device by itself. Method 5 
produces the highest AUC of all of the combination methods. This method highly favors 
the MDM posterior probabilities by a factor of 8. Figure 17E shows the ROC curve 
produced using Method 5, the weighted linear opinion pool of posteriors probabilities 
from each device. This combined method produced an AUC of .875, a sensitivity of 
74.4% and a specificity of 87.5%. This AUC is a 10.9% increase of the MDM alone and 
a 16.4% increase over the HRME alone. The second highest AUC (.824) was produced 
by method 2 where the lower posterior probability was chosen from the devices for each 
measurement site. The third highest AUC (.819) was produced by the weighted product 
of posterior probabilities where the MDM was again weighted highly favorably. 
112 
Table 10. The combinatorial methods and the performance achieved. 
The MDM was used to identify measurement sites with a greater 
than 90.7% probability of being neoplastic and the HRME was used 
to measure only these sites. The percent increase in AUC, 
sensitivity, and specificity values over the MDM alone are shown. 
The sensitivity of the MDM by itself was 90.7%, the specificity was 
38.5%, and the AUC was .789. Method 5 produced the highest 
increase in AUC. 
Combination Method 
] . Maximum posterior probability. 
2. Minimum posterior probability. 
3. Mean posterior probability. 
4. LOP. Weighted sum of posterior probabilities, 
weights determined from individual AUC for devices 
5. LOP. Weighted sum of posterior probabilities, 
weights determined from search. 
»;>»»<=•»* »'««»=. i i 
6. LOCiP. Product ol posterior probabilities. 
7. LOGP. Weighted Product o f posterior probabilities, 
weights determined from search. 
l * W r S 7 , I F , m „ - l 3 
8. Weights determined for device and class. 
9, MDM posterior probability used as HKMK prior probability. 
10. MDM posterior probability used as feature in HRME classifier. 
11. One classifier using features from both devices 
AUC 
.830 
.828 
.832 
.832 
.847 
.830 
.833 
.827 
.827 
.809 
818 
% inc. over 
MOM 
• 5.16 
<4.99 
+5.44 
+5.50 
+7.37 
+5.22 
+5.56 
+4,82 
+4.88 
+2.58 
+3,74 
Se 
76.7 
76.7 
76.7 
76.7 
86.1 
76.7 
83.7 
76.7 
76.7 
84.6 
744 
% Inc over 
MOM 
-14.7 
-14.7 
-14.7 
-14.7 
-44 
-14.7 
-6.98 
-14.7 
-14.7 
-5.98 
-17.3 
Sp 
84.6 
88.5 
84.6 
84.6 
80.8 
84.6 
80.8 
84.6 
84.6 
75,0 
84 6 
% inc over 
MOM 
+ 119.8 
+ 129.8 
+ 119.8 
+119.8 
+ 109.8 
+ 119.8 
+ 109.8 
+ 119 8 
+ 119 8 
+94.8 
+ 119.8 
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Figure 18. Results from the Directed Combinatorial Technique: 
when the MDM is first used to identify measurement sites with a 
sensitivity of 90%, and then the HRME is used to aid diagnosis of 
these measurement sites. A. Scatterplot of posterior probabilities 
per measurement site produced from data only from the MDM. The 
indicated discrimination line yields a sensitivity of 90.7% and a 
specificity of 38.5%. Measurements above this line are tested using 
the HRME. Measurements below this line are assumed non-
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neoplastic and assigned a posterior probability of 0. B. ROC curves 
produced by the MDM alone and from the 2 step method described. 
The AUC increases from .789 to .847 using this two step method. 
The qpoint is indicated on both ROC curves. The operating point 
yielding 90.7% sensitivity is also shown on the ROC produced from 
the MDM alone. 
Figure 18 and Table 10 show results from the Directed Combinatorial Technique. 
The MDM was first used to identify measurement sites with a sensitivity of 90.0%. For 
this analysis however, the closest operating point available from the linear classifier 
trained on the MDM data was at 90.7% sensitivity. The HRME data was then used to aid 
in diagnosis of only these measurement sites. Figure 18A is a scatter plot of posterior 
probabilities per measurement site produced from data only from the MDM. The 
indicated discrimination line yields a sensitivity of 90.7% and a specificity of 38.5%. 
Measurements below this line are assumed non-neoplastic. There are 14 measurement 
sites below the threshold, 10 sites are non-neoplastic and 4 are neoplastic confirmed by 
histopathology. HRME data is utilized in the combination methods with measurements 
above this line. ROC curves and performance metrics were computed from the 
combination of posterior probabilities from all measurement sites. 
The highest AUC from the Directed Combinatorial Technique was achieved using 
the weighted linear opinion pool of posteriors probabilities from each device (Table 10). 
The same weights used for both the Directed and Nondirected Combinatorial Techniques. 
Figure 18B shows the ROC curves produced by the MDM alone and from the Directed 
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Combinatorial Technique. The AUC increases from .789 to .847 using this method. The 
sensitivity drops from 90.7% to 86.1%. The specificity increases from 36.5% to 80.8%. 
The qpoint is indicated on both ROC curves. The operating point yielding 90.7% 
sensitivity is also shown on the ROC produced from the MDM alone. 
The highest AUC produced from the Nondirected Combinatorial Technique was 
.875 whereas the highest AUC achieved from the Directed Combinatorial Technique was 
.847. Data from 14 (20.3%) fewer measurements sites were required from the HRME for 
the Directed Combinatorial Technique. 
6.4 Discussion 
In this study, image data from two optical imaging devices were combined to 
make a quantitative, objective classification algorithm to distinguish between neoplastic 
and non-neoplastic oral mucosa. Both of the combination strategies improved 
classification performance over either device alone. The non-directed combinatorial 
technique yielded a 10.9% increase in AUC over the MDM alone and a 16.4% increase 
over the HRME alone. In addition to the combination of physically different 
measurement data provided by two different imaging modalities, independent imaging 
systems allow for the development of classification algorithms tailored to provide a 
desired sensitivity or specificity value. The Directed Combinatorial Technique described 
in this paper used the wide field imaging data alone, with a decision line set at 90% 
sensitivity as an initial screen. The abundant false positives remaining after this screen 
were reduced in a second step using combined wide field and high resolution imaging 
data. The selection of 90% sensitivity during the initial screen was made so that most of 
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the true positives would be captured while the number of measurements sites to be 
measured by the HRME is reduced. While the final result following the second screen 
did not achieve a 90% sensitivity (impossible unless the second method was able to 
classify with a 100% sensitivity at a nonzero specificity), the combined result still yields 
a significant improvement, 7.4% increase in AUC, over the MDM alone. Additionally, 
the final sensitivity at the Qpoint was higher and more reflective of the initial sensitivity 
threshold for the Directed Combinatorial Technique compared to the Nondirected (86.1% 
sensitivity for the Directed compared to 74.4% for the Nondirected). These results 
compared well to the weighted LOP classification results from the Nondirected 
Combinatorial Technique, but allows the user to better control the desired prediction 
efficiency, and in this case required measurement 20.3% fewer sites with the HRME. 
In a previous in vivo study using the MDM a sensitivity of 100% and specificity 
of 91.4% was achieved for discriminating neoplastic from non-neoplastic tissue [111]. 
The MDM performance was significantly worse in this study which yielded a sensitivity 
of 79.1% and a specificity of 69.2%. These differences may be due to the changes in 
resected specimens compared to in vivo tissue. Qualitative comparisons of the same 
tissue in vivo and ex vivo show differences in autofluorescence intensity which may 
correlate with the cessation of blood flow and other biochemical changes. 
Quantitative screening tools, such as the combinatorial wide field and high-
resolution imaging algorithm presented in the text, offers clinicians an objective means of 
examining the oral cavity. Since this technique requires minimal input from the user and 
a carries a very low per-use cost, higher volume and more frequent screening could be 
implemented, with the goal of discovering neoplastic lesions of the oral cavity at an 
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earlier, more treatable stage. Such early diagnosis would enable more conservative, 
tissue-sparing treatment options, with a better overall outcome for the patient. 
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CHAPTER 7: CONCLUSION 
7.1 Summary and Research Contributions 
Widefield optical imaging is an attractive technology for improving oral cancer 
detection and delineation. This method allows the for relatively fast inspection of the 
entire oral mucosal surface and can be implemented inexpensively compared to other 
biomedical imaging screening and diagnostic technologies such as MRI, CT, and 
mammography. Optical imaging has the potential to exploit anatomical and biochemical 
changes which occur during malignant progression in order to detect disease. Examples 
of these changes include increased vessel growth due to angiogenesis and the remodeling 
of the basement membrane. In order to successfully implement widefield optical imaging 
as a diagnostic tool for oral neoplasia, it is necessary to investigate and quantify the 
performance of this method as well as determine an ideal instrumentation design. These 
issues were the primary objectives of this dissertation work. 
The first part of this work, described in Chapter 3, was to design and construct a 
scientific grade widefield optical microscope with the capability of narrowband, 
autofluorescence, and polarized imaging modalities at a variety of exploratory 
illumination and collections wavelengths. This device is referred to as the Multipsectral 
Digital Microscope (MDM). The MDM can capture digital images at four narrowband 
illumination wavelengths, four autofluorescence excitation wavelengths, and with 
orthogonal and parallel polarization. The field of view is adjustable and can varied 
between approximately 1 cm to 7 cm. The spatial resolution is sufficient to capture 
vascular patterns common on the surface of oral mucosa. The MDM was constructed so 
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as to be portable and robust enough for in vivo imaging of patients. A custom mercury 
arc lamp illumination system was designed to provide sufficient illumination power for 
practical in vivo autofluorescence imaging with minimal motion artifacts, with exposure 
times of approximately .5 seconds. 
Qualitative observations were made from image data from normal volunteers and 
cancer patients. Under narrowband illumination conditions, differences in visible 
vascular patterns were apparent in normal volunteers. At blue illumination, fine vascular 
patterns were visible on anatomic regions such as the hard palate, soft palate, inner lip, 
and floor of mouth. Vessels appeared dark compared to surrounding tissue. As 
illumination went from blue to green to yellow to red, finer vasculature increasingly 
became less visible and while larger, deeper vessels became more visible. These 
observations were likely a due to a combination of increased penetration depth at longer 
wavelengths and differences in hemoglobin absorption at the illumination wavelengths. 
Orthogonal, or cross polarization imaging had the general effect of revealing increased 
vascularity. Autofluorescence imaging revealed differences in fluorescence intensity at 
different anatomical sites but relatively uniform intensity within each site. Highly 
keratinized sites such as the hard palate generally had a higher autofluorescence intensity. 
Vessels were often visible under autofluorescence mode. 
Multispectral imaging of oral lesions from patients revealed several qualitative 
observations which increased their visibility compared to white light. Relatively flat 
lesions without exophytic tumor growth commonly appeared to have negative contrast 
when compared to surrounding normal tissue using narrowband, autofluorescence, and 
cross polarized imaging. In narrowband imaging mode the negative contrast was more 
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easily observed using green and yellow illuminations and appeared to correlate with 
increased vasculature and vessel networks. In cross polarized, white light mode, these 
lesions appeared to be a darker red than surrounding tissue, also likely a result of 
vasculature networks below the mucosal surface. In autofluorescence mode, almost all 
lesions, including exophytic tumors, either appeared dark compared to surrounding 
normal tissue, or had an increased red fluorescence. These two observations have been 
previously reported in the literature. The decreased autofluorescence signal is most 
commonly attributed to the breakdown of collagen and elastin crosslinks in the 
extracellular matrix of the mucosal tissue. These crosslinks are brightly fluorescent and 
as tissue is remodeled during malignant progression, these crosslinks are thought to be 
degraded and restructured to allow new growth. A recent publication by our group helps 
to support this theory [6]. The decrease in autofluorescence appeared to be the most 
consistent observation which discriminated oral lesions with a diagnosis of dysplasia or 
cancer, from non-neoplastic tissue. The red fluorescence is commonly attributed to 
porphyrins, although it is unclear if the origins are endogenous or from bacterial growth. 
Based on these qualitative observations, image processing and computer aided 
diagnostics were implemented to determine an objective diagnosis. This part of the work 
is detailed in Chapters 4 and 5. This work began with an analysis of the autofluorescence 
images from 56 patients with previously determined oral lesions and 11 normal 
volunteers. Regions of interest (ROIs) of lesions areas and clinically normal areas were 
selected by a physician blinded to the autofluorescence images. The mean red to green 
ratio of pixel intensities of these regions, normalized to ROIs with a non-neoplastic 
diagnosis, were compared and it was found that using this single feature, dysplastic and 
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cancerous lesions could be discriminated from non-neopalstic regions with a sensitivity 
of 100% and a specificity of 91.4%. 
Probability maps of disease constructed from the classification results are also 
presented in Chapter 4. For the small number of samples tested, these maps qualitatively 
agree with histopathology and present an additional analysis tool for detection and/or 
delineation of the lesion extent. 
Previous studies have reported high sensitivity and specificity of oral lesion 
detection using autofluorescence based on qualitative observation and discrimination 
[21,55]. This work is the first in which the instrument performance was determined 
objectively using computer aided diagnosis. The accuracy of detection based only from 
the ratio of mean red to green feature suggests that this feature is highly conserved among 
premalignant and malignant lesions in the oral cavity. 
Chapter 5 significantly extends the computer aided diagnosis by including images 
from the narrowband and polarized imaging modalities. A plethora of features were 
extracted from these images based in part on the observations made in Chapter 3. 
Textural and frequency domain features were extracted under the hypothesis that these 
features might quantify the vascular pattern observations seen from lesions described in 
Chapter 3. Additional statistical and colorimetric features were also included in the 
analysis. Ultimately, features from the other modalities caused no increase in 
performance over the single feature of red to green ratio from the 405 nm excitation 
autofluorescence image, and no other features performed as well as this single feature. 
This finding suggests that features produced by vascular pattern increases observed in 
some oral lesions, and abnormal textural appearance of tumors, do not translate into a 
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quantitative features which are universal enough to provide an accurate diagnosis for a 
variety of oral lesions with a spectrum of diagnoses. This finding also supports the 
dominance of the decreased autofluorescence and the feature of red to green ratio for 
discrimination of non-neoplastic and neoplastic tissue. 
The analysis in Chapter 5 also included a comparison of image contrast computed 
from the different imaging modalities from lesions with different diagnostic grades, as 
well an attempt to classify lesions into one of three classes: non-neoplastic, dysplasia, or 
cancer. The largest majority of lesions had an increased contrast compared to white light 
at 405 nm excitation autofluorescence mode. Importantly, while this increase was 
statistically significant between non-neoplastic tissue and neoplastic tissue, there was no 
statistical difference between diagnostic grades within the neoplastic class. Similarly, 3-
class classification by computer aided diagnostics was largely unsuccessful. These 
results suggest that the tested imaging modalities, and the red to green ratio from 405 nm 
autofluorescence images in particular, are capable of discriminating non-neoplastic tissue 
from neoplastic tissue, but are not capable of making a more specific diagnosis. This 
finding may have significant implications concerning the clinical use of this technology. 
In Chapter 6, a high resolution microendoscope (HRME), capable of imaging 
cellular detail when used with a nuclear fluorescent dye, was used simultaneously with 
the MDM in a study of ex vivo oral resections presented. This work was conducted to 
determine if these two different optical devices could improve diagnostic performance 
over either alone. The quantities measured by the two devices are fundamentally 
different. The difference in the red to green ratio feature extracted from MDM images in 
normal and abnormal tissue was likely based on changes in the basement membrane of 
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tissue. The HRME system, conversely, images only the upper layers of the epithelium 
and the information content in largely based on cell-to-cell spacing and nuclear-to-
cytoplasmic ratio. Additionally, the MDM can be used to scan the entire oral mucosal 
surface quickly where as the HRME has a small field of view suggesting that it may be 
used for confirming or denying suspicious areas identified by the MDM. 
A pilot study of ex vivo tissue from 14 patients was conducted using image data 
collected from both the MDM and HRME. Multiple consensus hybrid techniques, which 
are methods of combining data from both devices to make a single diagnosis, were tested 
to explore the benefits of using the two devices together. An 11% increase in 
performance over the MDM alone and a 16% increase over the HRME alone was 
achieved using one combination strategy. While these are substantial increases, the final 
sensitivity and specificity achieved were only 74.4% and 84.6% respectively suggesting 
that the MDM analysis methods developed for in vivo tissue may not be as effective in ex 
vivo tissue. This performance difference could also conceivably be due to the small 
sample size in this study. A second combination strategy achieved similar results but 
required approximately 20% fewer measurements sites with the HRME. 
7.2 Future Research Directions 
There are several future research directions which would behoove the further 
development of widefield optical imaging for detection and delineation of oral neoplasia. 
Firstly, the MDM or another analogous portable system with autofluorescence capability 
at 405 nm excitation should be tested on a population with a high incidence of focal 
inflammation and other common benign conditions which are likely to occur in a 
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screening population. The patient population tested in the clinical studies in Chapters 3-6 
were from a tertiary care center where malignant and premalignant lesions had already 
been verified by biopsy. While the non-neoplastic regions selected for analysis almost 
always contained either inflammation, hyperkeratosis, hyperplasia, or a combination of 
these conditions, it was not tested if other common benign conditions would produce 
false positives. Furthermore, testing this technology on a larger patient population and in 
different geographic locations will help to confirm its effectiveness. 
Secondly, further analysis should be conducted into the selection of the clinically 
normal area used to normalize the red to green ratio. It was observed, but not quantified 
during the analysis conducted in this work, that the classification algorithm accuracy was 
dependent on the choice of location for this selected clinically normal region. While 
there was an attempt to select a clinically normal region contralateral to the lesions or 
distal, but oh the same anatomic site as the lesion of interest, this was not always possible 
because of the captured field of view available in the collected images. The classification 
was particularly sensitive to selected region when it was chosen near the dorsal tongue, 
which often had increased red fluorescence even in normal volunteers. 
Thirdly, the probability mapping analysis described in Chapter 4 should be 
expanded to reveal any greater potential. The probability mapping procedure was only 
demonstrated on a few patients, largely because of the practical limitations of obtaining 
histopathology for entire resected specimens. Histopathology may be easier to correlate 
to images of resected tissue and this may provide a viable pathway to further this 
analysis. Additionally, work should be conducted to help segment the lesion and define 
the lesion border based on the probability mapping. K-means clustering and other 
125 
unsupervised learning techniques may aid in this problem. The threshold for the lesion 
border can be altered and compared to full resection pathology maps to find appropriate 
values. Furthering this area has the potential of extending the use of widefield imaging to 
margin detection in addition to screening. 
Fourth, the instrument hybrid analysis described in Chapter 6 should be extended to 
other secondary instruments to help answer of the limitations of the MDM. Results from 
Chapter 5 indicate that the red to green ratio can discriminate non-neoplastic tissue from 
neoplastic tissue well, but likely cannot make a more specific diagnosis with the tested 
configuration. Clinically, more diagnostic information would be beneficial to guide 
treatment. Additionally, a confirmation of the MDM diagnosis by a device which 
measures a fundamentally different morphological or biochemical feature would be 
beneficial. Depth sensitive point probe fluorescence and reflectance spectroscopy is a 
well tested technology which could be combined with the widefield approach. In a 
complementary fashion, the widefield imaging may help to answer some of the 
limitations of point probe devices by identifying suspicious lesions after screening the 
entire oral mucosa, a procedure which is impractical with any device with a small field of 
view or measurement area. 
Finally, closer investigation into the biological origins of the most important 
imaging features observed in this work would help in understanding why this method 
works well in a tertiary care patient population, and if it should generalize to larger, more 
diverse populations with more benign conditions. Additionally, understanding the origins 
of these observations may help to explain why the natural discrimination line when using 
the red to green ratio appears to be between non-neopalstic tissue and lesions with any 
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grade of dysplasia or cancer, including mild dysplasia. In order to supplement the work 
already done by Pavlova et al. in this area [6] I would recommend conducting a tissue 
microarray study to compare regions with decreased autofluorescence to regions with 
normal autofluorescence. Immunohistochemical staining of suspected causes such as 
MMPs, known to breakdown the basement membrane, and collagen and elastin fibers 
could shine light on the underlying biological functions being measured with the 
autofluorescence imaging. 
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